Intracerebral haemorrhage

I9_ICH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I61 Hospital discharge: ICD-9 — 431 Hospital discharge: ICD-8 — 431 Cause of death: ICD-10 — I61 Cause of death: ICD-9 — 431 Cause of death: ICD-8 — 431 2 out of 7 registries used, show all original rules.	6760
4. Check minimum number of events None	6760
5. Include endpoints None	6760
6. Filter based on genotype QC (FinnGen only)	5886

Control definitions (FinnGen only)

Control exclude: I9_STR_EXH, I9_TIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I60-I69
Name in latin: Haemorrhagia intracerebralis

NAME	I9_ICH
CONTROL_EXCLUDE	I9_STR_EXH\|I9_TIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I61
HD_ICD_9	431
HD_ICD_8	431
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I61
COD_ICD_9	431
COD_ICD_8	431
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Intracerebral haemorrhage based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	79457	36219	41747
Only index persons	46894	21914	24980
Unadjusted period prevalence (%)
Whole population	1.11	1.04	1.17
Only index persons	0.88	0.81	0.95
Median age at first event (years)
Whole population	70.68	74.26	67.66
Only index persons	71.33	75.26	67.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5886	2384	3502
Unadjusted period prevalence (%)	1.30	0.85	1.61
Median age at first event (years)	71.84	72.25	71.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6084: Matched controls
60825

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

5.6

316.3

642

1251

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

11.6

307.7

360

328

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

503.8

307.7

380

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

28.7

307.7

306

112

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1109.4

307.7

316

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

162.4

307.7

1304

102

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

278.7

307.7

1542

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

38.6

307.7

415

115

AA1AD

NOMESCO Finland

CT of head and brain

6.6

307.7

3616

11089

G40.9

ICD-10 Finland

Epilepsy, unspecified

8.1

307.7

504

671

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

13.1

307.7

358

289

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3935.6

307.7

2530

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

24.4

307.7

389

170

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

8.3

307.7

849

1160

N18

ICPC

Paralysis/weakness

17.7

307.7

428

259

S06.3

ICD-10 Finland

Focal brain injury

13.7

307.7

357

275

K90

ICPC

Stroke/cerebrovascular accident

39.6

307.7

762

219

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4503599627370496.0

307.7

2590

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

9.0

307.7

423

500

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

307.7

998

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.0

307.7

544

734

N03AX14

ATC

levetiracetam; systemic

12.6

307.7

580

504

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

16.2

307.7

1149

863

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

307.7

387

PA2AD

NOMESCO Finland

CT angiography of brain

31.3

307.7

270

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

13.1

307.7

392

319

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

3373.3

307.7

330

K91

ICPC

Cerebrovascular disease

24.7

307.7

343

147

AAF00

NOMESCO Finland

Ventriculostomy

34.2

307.7

234

XA800

NOMESCO Finland

Neuropsychological investigation

10.6

307.7

532

544

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

42.5

307.7

715

190

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

12.9

307.7

339

278

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

307.7

2206

9236

R4120

NOMESCO Finland

Occupational therapy

5.7

307.7

656

1267

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

31.4

303.8

198

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

283.5

270

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.4

275.2

757

1897

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

1382.5

272.7

264

N03AF02

ATC

oxcarbazepine; oral

7.5

272.7

406

577

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

270.9

1708

7259

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

388.0

262.1

262

R4150

NOMESCO Finland

Neuropsychological rehabilitation

49.7

243.8

141

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

231.7

221

H53.4

ICD-10 Finland

Visual field defects

9.3

223.7

274

307

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

13.7

215.5

202

152

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.8

215.1

514

1145

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

19.0

209.2

165

R47.0

ICD-10 Finland

Dysphasia and aphasia

18.9

207.3

164

N19

ICPC

Speech disorder

12.8

206.6

202

163

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

22.8

204.2

149

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

77.8

199.9

107

PA6AD

NOMESCO Finland

CT of neck arteries

6.9

192.1

305

463

R4130

NOMESCO Finland

Speech therapy

7.0

191.5

300

449

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

634.0

187.8

185

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

16.5

177.7

150

T90.5

ICD-10 Finland

Sequelae of intracranial injury

11.0

177.0

190

177

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

6.3

173.5

300

497

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

59.0

166.2

I63.8

ICD-10 Finland

Other cerebral infarction

88.2

165.2

N03AG01

ATC

valproic acid; systemic, rectal

4.0

164.3

492

1299

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

9.3

161.2

196

217

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.9

159.3

292

512

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

29.6

153.9

102

I61

ICD-10 Finland

Intracerebral haemorrhage

201.3

151.5

157

N03AB02

ATC

phenytoin; systemic

8.4

150.2

197

240

N03AX18

ATC

lacosamide; systemic

16.3

148.3

126

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

+∞

145.4

139

Z2445

NOMESCO Finland

Psychologist

6.0

143.4

261

454

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

142.1

614

2058

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

698.9

139.4

137

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

33.0

137.3

WX892

NOMESCO Finland

Monitored bed care

3.0

134.6

678

2479

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

28.8

131.5

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

1295.7

130.7

127

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.5

130.3

332

774

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

6.9

130.1

205

308

AA5PD

NOMESCO Finland

CT examination of brain pefusion

22.5

127.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

126.8

2421

15499

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

188.2

124.0

129

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

10.8

122.3

133

126

G40.10

ICD-10 Finland

Simple partial seizures

14.5

118.6

107

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

27.9

118.4

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

12.4

118.2

117

4310A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]

+∞

118.1

113

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

46.5

117.4

R1260

NOMESCO Finland

Evaluation of communicative skills

6.7

116.6

187

286

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.6

116.6

283

634

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

16.1

113.9

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

14.7

108.3

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

29.1

108.0

PA7BD

NOMESCO Finland

CT angiography of neck and brain

9.1

105.3

129

144

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

215.7

102.8

106

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

22.0

100.2

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

17.8

100.0

WX730

NOMESCO Finland

Conventional respirator

5.4

98.5

196

370

G45.3

ICD-10 Finland

Amaurosis fugax

28.5

96.8

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

13.3

93.8

G41.9

ICD-10 Finland

Status epilepticus, unspecified

12.4

93.3

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

19.7

93.0

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

20.2

91.5

4311A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]

+∞

90.8

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

13.5

90.4

W19

ICD-10 Finland

Unspecified fall

2.3

89.2

782

3701

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

30.8

88.5

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.6

88.2

169

308

N28

ICPC

Limited function/disability (N)

5.0

87.1

191

393

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

6.8

86.7

136

203

N03AF01

ATC

carbamazepine; oral, rectal

2.9

86.5

422

1505

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

9.1

84.9

104

116

4319X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]

+∞

84.6

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

83.0

621

2740

183

Kela drug reimbursment

Lamotrigin and topiramate

10.7

82.0

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.0

81.4

236

605

FFW96

NOMESCO Finland

Other operation on atria

22.9

81.1

G81.9

ICD-10 Finland

Hemiplegia, unspecified

9.4

81.0

105

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

79.9

1117

6284

R51.80

ICD-10 Finland

Headache

2.2

79.3

757

3699

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

76.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

75.3

4117

33673

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

73.3

1145

6662

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.1

72.8

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

11.1

72.7

B01AA03

ATC

warfarin; systemic

1.7

71.4

1637

10670

A28

ICPC

Limited function/disability NOS

1.7

69.9

1544

9948

R47.1

ICD-10 Finland

Dysarthria and anarthria

7.3

69.8

102

141

ZXD05

NOMESCO Finland

Urgent procedure

1.7

69.0

1847

12530

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

36.1

68.6

C08CA01

ATC

amlodipine; oral

1.6

68.4

2656

19766

G40

ICD-10 Finland

Epilepsy

8.1

65.6

110

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

65.3

371

1431

N05BA09

ATC

clobazam; oral

12.2

65.1

GBB00

NOMESCO Finland

Tracheostomy

4.9

62.9

138

284

S06.2

ICD-10 Finland

Diffuse brain injury

5.9

61.9

111

190

S06.8

ICD-10 Finland

Other intracranial injuries

14.6

61.3

205

Kela drug reimbursment

Chronic hypertension

1.6

61.1

2124

15277

R41.0

ICD-10 Finland

Disorientation, unspecified

2.8

60.0

317

1177

B01AC04

ATC

clopidogrel; oral

1.8

59.6

1064

6410

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

8.5

59.6

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

4.0

59.4

169

427

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

583.6

58.8

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

16.5

58.1

B01AC07

ATC

dipyridamole; systemic

2.6

57.6

364

1478

M03BX01

ATC

baclofen; systemic

4.5

56.6

141

322

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

11.5

56.0

I63

ICD-10 Finland

Cerebral infarction

17.4

54.9

S06.0

ICD-10 Finland

Concussion

2.0

54.8

666

3537

SPAT1216

SPAT

Assessment of functional ability

1.7

53.7

1160

7357

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

8.1

53.7

K89

ICPC

Transient cerebral ischaemia

9.4

53.6

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

53.3

486

2317

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

16.2

52.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

52.7

1820

12966

G40.89

ICD-10 Finland

Other epilepsy

11.3

52.6

N88

ICPC

Epilepsy

8.1

52.4

S01.0

ICD-10 Finland

Open wound of scalp

2.0

51.5

600

3136

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

10.7

51.5

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

51.4

1990

14533

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.7

51.0

120

262

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

19.2

51.0

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

12.0

49.7

SPAT1229

SPAT

Assessment of need for aid

2.0

49.2

587

3093

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

48.8

380

1696

L28

ICPC

Limited function/disability (L)

1.6

48.6

1383

9383

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

5.0

48.2

104

211

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

48.0

460

2235

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

15.9

47.7

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.1

46.9

197

G91.1

ICD-10 Finland

Obstructive hydrocephalus

9.7

46.5

WX872

NOMESCO Finland

Intensive care

2.3

46.3

364

1630

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

5.8

45.7

144

Z3226

NOMESCO Finland

Physiotherapist

1.7

45.5

1037

6640

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

45.4

183

583

R55

ICD-10 Finland

Syncope and collapse

1.8

45.3

785

4659

ZXD35

NOMESCO Finland

Usual procedure

2.7

44.7

248

944

C09AA05

ATC

ramipril; oral

1.5

44.4

1727

12540

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

44.0

394

1862

C02AC05

ATC

moxonidine; oral

2.3

43.8

343

1534

R4110

NOMESCO Finland

Physiotherapy

1.5

43.4

1559

11114

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

7.1

43.1

R53

ICD-10 Finland

Malaise and fatigue

1.5

42.6

1466

10347

Z50.5

ICD-10 Finland

Speech therapy

5.0

42.6

187

R4130, ,

SPAT

9.7

42.1

R4120, ,

SPAT

4.2

41.7

110

263

ZXY02

NOMESCO Finland

Neuropsychologist

10.1

41.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

41.3

1016

6618

N05AH04

ATC

quetiapine; oral

1.7

41.2

872

5464

R42

ICD-10 Finland

Dizziness and giddiness

1.5

41.2

1392

9775

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.0

40.1

182

622

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

39.5

440

2257

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

7.0

38.9

XA400

NOMESCO Finland

EEG

7.1

38.9

N80

ICPC

Head injury other

3.2

37.8

154

494

Z2446

NOMESCO Finland

Social worker

2.1

37.6

366

1785

F80.1

ICD-10 Finland

Expressive language disorder

6.9

36.4

D21

ICPC

Swallowing problem

3.5

36.2

125

362

XX2BT

NOMESCO Finland

Other injection with X-ray guidance

10.9

35.5

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.8

35.5

165

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

35.3

1059

14966

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

35.2

247

1052

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

35.2

1039

7048

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

349.2

35.0

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

181.0

34.8

43190

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, hypertonia non indicata

+∞

34.4

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

34.2

387

1996

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

34.1

625

3754

AAL00

NOMESCO Finland

Endovascular occlusion of intracranial aneurysm

13.4

33.9

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.3

33.8

128

393

G41.2

ICD-10 Finland

Complex partial status epilepticus

12.3

33.2

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

7.1

33.0

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

32.5

519

2993

N05AX08

ATC

risperidone; systemic

1.7

32.5

616

3733

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

8.9

32.4

A06AD11

ATC

lactulose; oral

1.5

32.3

1130

7942

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

5.5

32.0

111

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.6

31.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

31.8

1019

7022

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

7.2

31.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

31.6

693

4364

L01AX03

ATC

temozolomide; systemic

5.4

31.4

113

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

31.4

309

1514

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.9

31.2

235

M01AH05

ATC

etoricoxib; oral

0.7

31.1

1997

24675

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

31.0

734

4712

S02.11

ICD-10 Finland

Fracture of base of skull, open

7.0

30.9

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

9.3

30.9

C07AB07

ATC

bisoprolol; oral

1.4

30.8

3151

26750

N29

ICPC

Neurological sympt/complt other

3.0

30.1

135

459

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

6.4

29.4

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.4

29.3

104

307

2161

FHL

Neck ligation, big brain

6.9

29.2

4318X

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS ALIA DEFINITA]

+∞

29.2

43199

ICD-8 Finland

Cerebral haemorrhage, Without mention of hypertension

+∞

29.2

SPAT1234

SPAT

Support of social functional capacity

1.9

28.3

399

2213

C10AA01

ATC

simvastatin; oral

1.4

28.2

2727

22820

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.0

27.9

118

WX882

NOMESCO Finland

High dependency care

2.5

27.7

178

729

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

27.6

215

959

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

27.1

184

772

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.7

27.0

147

555

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

9.7

26.7

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

26.7

617

9331

N06AB04

ATC

citalopram; systemic

1.5

26.6

1039

7434

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

10.4

26.2

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

26.2

218

1000

AA9CW, ,

NOMESCO Finland

25.8

26.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

26.0

991

7054

XX3XW, ,

NOMESCO Finland

5.7

25.9

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

31.1

25.9

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

73.0

25.8

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

135.6

25.6

S06.4

ICD-10 Finland

Epidural haemorrhage

9.2

25.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

25.4

359

1992

N06AB10

ATC

escitalopram; oral

1.5

25.3

781

5317

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

25.1

25.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

25.1

293

1527

F10.24

ICD-10 Finland

Alcohol depence active use

3.6

24.9

226

315

Kela drug reimbursment

Clopidogrel

4.2

24.8

155

N03AX09

ATC

lamotrigine; oral

2.5

24.8

160

657

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.9

24.7

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

23.5

24.7

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

7.3

24.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

24.0

155

4351A

ICD-9 Finland

Transient cerebral ischaemia, Vertebral artery syndrome

+∞

24.0

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

7.2

23.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

23.7

308

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

23.7

283

1486

C07AB02

ATC

metoprolol; systemic

1.4

23.6

1380

10600

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

23.3

865

6113

XCK00

NOMESCO Finland

Perimetry

1.8

23.3

379

2194

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.0

23.3

163

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

23.2

312

1703

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

23.2

243

1219

N06AX11

ATC

mirtazapine; oral

1.4

23.0

1696

13508

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

22.5

216

1049

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

22.4

654

4392

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

22.4

161

694

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

22.4

283

1514

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

45.2

22.3

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

22.1

570

3724

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.8

22.0

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.1

22.0

301

P20

ICPC

Memory disturbance

1.4

22.0

1053

7805

43100

ICD-8 Finland

Cerebral haemorrhage, Intracerebralis, cum hypertonia

+∞

21.9

H53.2

ICD-10 Finland

Diplopia

2.3

21.8

173

778

N03AX23

ATC

brivaracetam; systemic

29.1

21.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

21.8

459

2853

SPAT1254

SPAT

Administration of medicine

1.5

21.7

904

6526

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

4.6

21.7

112

C08CA05

ATC

nifedipine; systemic

1.7

21.5

416

2527

127

Kela drug reimbursment

Transplant complication

3.4

21.3

226

OAB43, ,

SPAT

0.5

21.2

215

4084

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

20.9

208

1024

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

5.0

20.9

P15

ICPC

Chronic alcohol abuse

2.5

20.7

127

509

AAK80

NOMESCO Finland

Partial excision of skull cap

77.0

20.7

WYA20

NOMESCO Finland

Home visit

2.3

20.6

160

714

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.3

20.4

237

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

20.3

331

1916

WW200, ,

SPAT

0.7

20.3

869

11695

C09AA02

ATC

enalapril; systemic

1.4

20.2

1276

9887

RS221, ,

NOMESCO Finland

3.1

20.2

269

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

20.2

122

486

RS313, ,

NOMESCO Finland

6.2

20.2

AAK00

NOMESCO Finland

Cranioplasty

32.6

20.2

A10AB05

ATC

insulin aspart; parenteral

1.7

20.1

415

2563

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

20.1

650

4460

C08CA02

ATC

felodipine; oral

1.5

19.9

640

4384

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.0

19.6

284

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.0

19.5

275

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

19.4

1169

8983

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

19.3

906

6677

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.8

19.3

A12BA01

ATC

potassium chloride; oral

1.7

19.3

359

2159

WX704

NOMESCO Finland

Intubation

1.7

19.2

383

2345

C10AA05

ATC

atorvastatin; oral

1.3

19.1

2316

19651

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

7.2

19.0

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

19.0

294

1677

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.5

18.9

184

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.5

18.9

119

484

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.0

18.8

134

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

18.7

1459

11653

Z3231

NOMESCO Finland

Registered nurse

1.3

18.7

1439

11474

N05BA01

ATC

diazepam; systemic, rectal

1.5

18.6

669

4688

G81.1

ICD-10 Finland

Spastic hemiplegia

20.9

18.6

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

14.2

18.5

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

14.2

18.5

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

6.2

18.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

18.3

732

5235

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

18.3

283

1615

E85.4

ICD-10 Finland

Organ-limited amyloidosis

7.1

18.2

G93.90

ICD-10 Finland

Brain death

52.6

17.9

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

17.7

340

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.7

17.7

4350A

ICD-9 Finland

Transient cerebral ischaemia, Basilar artery syndrome

+∞

17.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

17.5

875

6513

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.8

17.2

134

2BD01, ,

NOMESCO Finland

6.2

17.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

17.1

115

483

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

16.9

1845

15380

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

16.9

661

4704

R40.2

ICD-10 Finland

Coma, unspecified

3.2

16.9

203

YJA10

NOMESCO Finland

Excision of liver from cadaver donor

63.5

16.7

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

16.7

607

8450

4359X

ICD-9 Finland

Transient cerebral ischaemia, Unspecified transient cerebral ischaemia

+∞

16.7

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.4

16.5

115

490

C03AA03

ATC

hydrochlorothiazide; oral

1.5

16.3

569

3958

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

16.0

118

W06

ICD-10 Finland

Fall involving bed

3.0

16.0

236

GBB03

NOMESCO Finland

Percutaneous tracheostomy

24.5

16.0

N30.0

ICD-10 Finland

Acute cystitis

1.4

15.9

826

6177

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.3

15.9

185

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.9

15.9

215

1178

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

15.8

161

PA2JT

NOMESCO Finland

Very extensive embolisation of arterio-venous malformation of the brain

60.1

15.7

B01AB05

ATC

enoxaparin; parenteral

1.3

15.7

1641

13584

C03CA01

ATC

furosemide; systemic

1.3

15.7

2313

19955

WW806

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by doctor

85.3

15.6

PA2HT

NOMESCO Finland

Extensive embolisation of arterio-venous malformation of the brain

160.4

15.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

15.4

376

2420

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

15.2

344

A29

ICPC

General symptom/complaint other

1.4

15.2

732

5404

G41.0

ICD-10 Finland

Grand mal status epilepticus

13.0

15.1

ZXC95

NOMESCO Finland

Use of surgical navigator

3.0

15.1

217

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

6.3

15.0

U04

ICPC

Incontinence urine

1.6

15.0

371

2398

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.0

14.9

102

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.4

14.9

102

432

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

5.2

14.8

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

14.8

252

1479

TAB00

NOMESCO Finland

Lumbar puncture

2.0

14.7

169

877

G41.8

ICD-10 Finland

Other status epilepticus

16.5

14.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

14.7

688

5053

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

14.7

214

1201

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

14.6

597

4280

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

14.6

537

3774

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.6

711

5259

R11

ICD-10 Finland

Nausea and vomiting

1.5

14.6

427

2865

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.2

14.4

171

L04AA06

ATC

mycophenolic acid; systemic

2.6

14.4

330

A04

ICPC

Weakness/tiredness general

1.4

14.4

827

6281

I60.4

ICD-10 Finland

Subarachnoid haemorrhage from basilar artery

17.0

14.3

K78

ICPC

Atrial fibrillation/flutter

1.5

14.2

527

3709

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

3.8

14.1

111

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

14.1

145

725

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

14.0

3908

42018

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

2.8

13.8

245

I60

ICD-10 Finland

Subarachnoid haemorrhage

53.4

13.8

TK800

NOMESCO Finland

Hemodialysis

2.2

13.7

116

538

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

10.4

13.7

43198

ICD-8 Finland

Cerebral haemorrhage, Aliandefinita, hypertonia non indicata

+∞

13.5

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

13.5

102

452

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.8

13.4

227

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

5.2

13.4

H3603, E103,

ICD-10 Finland

3.8

13.4

106

SPAT1301

SPAT

No procedures

1.3

13.4

1658

13958

Z51.5

ICD-10 Finland

Palliative care

1.4

13.4

602

4391

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

13.3

295

1857

Y86

ICD-10 Finland

Sequelae of other accidents

3.8

13.3

102

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

4.0

13.1

A98

ICPC

Health maint/preventive medicine

0.8

13.1

4480

47350

3A064, ,

NOMESCO Finland

4.3

13.1

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.8

13.0

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.1

12.9

178

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.7

12.9

225

1332

G94.2

ICD-10 Finland

Hydrocephalus in other diseases classified elsewhere

50.1

12.8

C08DB01

ATC

diltiazem; oral

1.5

12.8

380

2557

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

9.6

12.7

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.6

12.6

267

1662

F01.8

ICD-10 Finland

Other vascular dementia

6.0

12.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

12.6

155

G942, I615,

ICD-10 Finland

+∞

12.5

C09BA02

ATC

enalapril and diuretics; systemic

1.4

12.4

492

3505

SPAT1252

SPAT

Overall medication plan or its review

1.5

12.4

394

2691

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

12.3

257

1594

742, ,

NOMESCO Finland

5.3

12.3

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

4.9

12.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

12.1

335

2220

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

12.4

12.1

Z43.0

ICD-10 Finland

Attention to tracheostomy

11.0

12.0

G81

ICD-10 Finland

Hemiplegia

46.7

11.9

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.3

11.9

130

EB1VA, ,

NOMESCO Finland

0.7

11.8

347

5048

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

11.8

130

668

OAA67, ,

SPAT

0.5

11.7

134

2457

SPAT1042

SPAT

Guidance concerning balance maintenance

3.6

11.7

107

G30.8

ICD-10 Finland

Other Alzheimer disease

1.7

11.7

202

1193

AAF15

NOMESCO Finland

Ventriculoatrial shunt

4.7

11.6

OAA80, ,

SPAT

0.4

11.6

1284

AA1AA

NOMESCO Finland

Head X-ray examination

2.8

11.5

201

L04AD02

ATC

tacrolimus; systemic

3.3

11.5

123

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

9.2

11.5

4341A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral embolism

+∞

11.5

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

11.5

43599

ICD-8 Finland

Transient cerebral ischaemia, Without mention of hypertension

+∞

11.5

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

11.4

350

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

11.4

1027

8296

N05CF01

ATC

zopiclone; oral

1.2

11.4

1781

15324

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.7

11.4

462

6339

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

11.4

515

3757

D68.8

ICD-10 Finland

Other specified coagulation defects

3.1

11.3

144

R51

ICD-10 Finland

Headache

1.8

11.3

175

1001

E87.6

ICD-10 Finland

Hypokalaemia

1.7

11.3

187

1092

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

8.3

11.3

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

2.9

11.2

182

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

11.2

2613

23383

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.6

11.1

101

G91.8

ICD-10 Finland

Other hydrocephalus

12.7

11.1

N05BA04

ATC

oxazepam; oral

1.3

11.1

1287

10719

N03AX16

ATC

[U] pregabalin

1.3

11.0

1069

8716

G44.2

ICD-10 Finland

Tension-type headache

1.4

11.0

475

3438

EB4VA, ,

NOMESCO Finland

0.6

11.0

250

3835

I67.2

ICD-10 Finland

Cerebral atherosclerosis

3.7

10.9

R33

ICD-10 Finland

Retention of urine

1.4

10.9

557

4148

W17

ICD-10 Finland

Other fall from one level to another

1.7

10.9

186

1096

7803A

ICD-9 Finland

General symptoms, Convulsions

3.1

10.9

148

A10AE04

ATC

insulin glargine; parenteral

1.4

10.8

493

3601

F05.8

ICD-10 Finland

Other delirium

2.6

10.8

226

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.0

10.7

118

606

A86

ICD-10 Finland

Unspecified viral encephalitis

4.0

10.7

E85.9

ICD-10 Finland

Amyloidosis, unspecified

4.9

10.7

2132

FHL

Ventricular operators sunt

28.0

10.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

10.7

286

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.0

10.7

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.6

729

5674

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

8.0

10.6

GD1AA, ,

SPAT

0.6

10.6

254

3852

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

10.5

294

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

10.5

1180

9779

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.4

10.5

295

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

4.5

10.5

43300

ICD-8 Finland

Cerebral thrombosis, Wtih hypertension (benign)

+∞

10.4

N03AE01

ATC

clonazepam; systemic

1.6

10.4

251

1614

R13

ICD-10 Finland

Dysphagia

1.5

10.4

352

2435

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

5.4

10.4

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

2.9

10.3

169

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

8.2

10.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

10.3

289

1924

SPAT1244

SPAT

Occupational therapy

2.6

10.2

227

RS222, ,

NOMESCO Finland

2.4

10.2

287

N03AX15

ATC

zonisamide; oral

13.1

10.1

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.3

10.1

331

Z72.1

ICD-10 Finland

Alcohol use

2.7

10.1

199

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

7.9

10.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

10.0

137

756

R01AD12

ATC

fluticasone furoate; nasal

0.8

10.0

685

8693

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.0

F01

ICD-10 Finland

Vascular dementia

3.4

10.0

G93.4

ICD-10 Finland

Encephalopathy, unspecified

4.6

10.0

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

4.6

10.0

Z50.1

ICD-10 Finland

Other physical therapy

1.6

9.9

251

1632

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

9.9

594

4535

F03

ICD-10 Finland

Unspecified dementia

1.5

9.9

361

2535

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

9.9

124

667

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

2.5

9.8

231

APM

Auricle closure

26.0

9.8

G93.6

ICD-10 Finland

Cerebral oedema

26.0

9.8

S09.9

ICD-10 Finland

Unspecified injury of head

2.2

9.8

381

K99

ICPC

Cardiovascular disease other

1.7

9.8

158

917

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.5

9.8

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

9.7

117

620

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

9.7

122

656

C08CA13

ATC

lercanidipine; oral

1.3

9.7

785

6248

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

9.7

317

2179

N01

ICPC

Headache

1.5

9.7

323

2229

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

2.7

9.7

192

PA2GT

NOMESCO Finland

Embolisation of arterio-venous malformation of the brain

55.1

9.6

I63.6

ICD-10 Finland

Cerebral infarction due to cerebral venous thrombosis, nonpyogenic

55.1

9.6

A10AC01

ATC

insulin (human); parenteral

1.4

9.6

393

2819

F21, ,

ICPC

2.4

9.6

258

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

9.6

355

2500

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

9.5

405

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

9.5

158

925

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.1

9.5

128

J01EA01

ATC

trimethoprim; systemic

1.2

9.4

1275

10771

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

9.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

9.4

322

2235

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

9.3

285

1932

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

2.5

9.3

237

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

4.5

9.3

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

8.7

9.3

ZXD00

NOMESCO Finland

Emergency procedure

1.7

9.2

152

889

V03AE02

ATC

sevelamer; oral

3.4

9.1

N05CD08

ATC

midazolam; nasal, systemic

1.8

9.1

130

729

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

11.5

9.0

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

4.6

9.0

3313A

ICD-9 Finland

Other cerebral degenerations, Communicating hydrocephalus

15.6

9.0

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.1

9.0

381

R04.0

ICD-10 Finland

Epistaxis

1.4

9.0

431

3177

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

9.0

143

828

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

8.9

129

725

N99

ICPC

Neurological disease other

2.3

8.9

298

R01AD58

ATC

fluticasone, combinations; nasal

0.7

8.9

465

6134

ZXC40

NOMESCO Finland

Use of ultrasound

3.2

8.7

108

-2, ,

ICPC

2.8

8.7

151

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

7.2

8.7

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

8.7

138

798

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

8.7

305

2127

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

3.2

8.6

104

RS220, ,

NOMESCO Finland

2.4

8.6

228

RS340, ,

NOMESCO Finland

4.8

8.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

8.6

1420

12230

SPAT1139

SPAT

Nutrition survey

1.6

8.6

172

1060

K29

ICPC

Cardiovascular sympt/complt other

1.5

8.6

237

1575

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.6

8.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

8.5

209

1352

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

9.0

8.5

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

8.5

134

774

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

8.5

432

3216

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

6.4

8.5

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.0

8.4

473

A12AA04

ATC

calcium carbonate; oral

2.0

8.4

398

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

8.4

1250

10653

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.8

8.4

149

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

4.9

8.3

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

+∞

8.3

4349A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]

+∞

8.3

43191

ICD-8 Finland

Cerebral haemorrhage, Subduralis non traumatica, hypertonia non indicata

+∞

8.3

4331A

ICD-9 Finland

Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]

+∞

8.3

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

8.3

226

1497

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.3

496

3784

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.9

8.3

497

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

8.3

394

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

8.3

121

684

X58

ICD-10 Finland

Exposure to other specified factors

1.3

8.2

566

4404

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

8.2

365

2657

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

8.2

344

2479

S42.4

ICD-10 Finland

Fracture of lower end of humerus

2.3

8.2

252

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

8.1

582

7351

N06AX26

ATC

vortioxetine; oral

1.5

8.1

233

1562

XX9XW, ,

NOMESCO Finland

3.1

8.1

103

R3130

NOMESCO Finland

Training in activities of daily lining

33.4

8.1

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

8.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.0

8.1

398

V03AA01, ,

ATC

2.1

8.0

319

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

8.0

454

3438

A10AE05

ATC

insulin detemir; parenteral

1.5

8.0

236

1592

R5130, ,

SPAT

3.1

7.9

N02AA05

ATC

oxycodone; systemic

1.2

7.9

1123

9521

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.4

7.9

H36.01

ICD-10 Finland

Diabetic maculopathy

2.2

7.9

282

XX4AW, ,

NOMESCO Finland

13.0

7.9

N03AX22

ATC

perampanel; oral

13.0

7.9

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

7.9

110

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.7

7.8

123

710

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

6.1

7.8

WX002

NOMESCO Finland

Sedation and analgesia

1.2

7.8

922

7665

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.7

7.8

133

786

L15

ICPC

Knee symptom/complaint

0.8

7.8

763

9284

M25.5

ICD-10 Finland

Pain in joint

0.8

7.8

928

11053

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

7.8

187

1206

N06AX21

ATC

duloxetine; oral

1.3

7.7

431

3253

N02BE01

ATC

paracetamol; systemic, rectal

1.2

7.7

4782

45829

ZX124

NOMESCO Finland

Perfusion of a organ or target

45.0

7.7

S70.0

ICD-10 Finland

Contusion of hip

1.5

7.7

218

1457

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

1.6

7.7

164

1028

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

4.3

7.7

N07

ICPC

Convulsion/seizure

5.9

7.7

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

4.5

7.6

SPAT1172

SPAT

Guidance concerning hydration

1.6

7.6

160

999

A41.9

ICD-10 Finland

Sepsis, unspecified

1.5

7.6

209

1388

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

7.6

742

6037

WW805

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse

18.4

7.6

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

25.0

7.6

N05CD07

ATC

temazepam; oral

1.3

7.5

708

5734

P03

ICPC

Feeling depressed

1.5

7.5

240

1644

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

7.5

216

1449

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.4

7.5

218

L04AD01

ATC

ciclosporin; systemic

2.1

7.5

301

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.5

7.5

182

TQW40, ,

SPAT

0.7

7.5

224

3245

K91

ICD-10 Finland

Postprocedural disorders of digestive system, not elsewhere classified

80.2

7.4

2213

FHL

Hematoma removal, intracerebral or cerebral palsy reversion

80.2

7.4

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

4.4

7.4

3AX01, ,

NOMESCO Finland

4.4

7.4

S22.3

ICD-10 Finland

Fracture of rib

1.4

7.4

351

2583

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.2

7.4

270

SPAT1251

SPAT

Organisation of medication

1.5

7.4

189

1237

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

7.4

109

RS122, ,

NOMESCO Finland

6.0

7.4

J01CA08

ATC

pivmecillinam; oral

1.2

7.3

1627

14356

Z03

ICPC

Housing/neighbourhood problem

2.7

7.3

137

OAB48, ,

SPAT

0.6

7.3

142

2255

E86

ICD-10 Finland

Volume depletion

1.6

7.3

154

963

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

6.8

7.3

C02CA01

ATC

prazosin; oral

1.8

7.3

109

622

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

7.3

640

5144

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

7.2

1137

13192

J01DA01

ATC

[U] cefalexin

1.2

7.2

3062

28395

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

7.2

181

1179

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

7.2

1844

16456

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

7.2

362

4805

RP120, ,

NOMESCO Finland

20.0

7.1

NA3BG, ,

SPAT

0.4

7.1

774

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.3

7.1

S02.80

ICD-10 Finland

Fractures of other skull and facial bones, closed

4.1

7.1

T74.1

ICD-10 Finland

Physical abuse

2.5

7.1

169

N03AX11

ATC

topiramate; oral

2.1

7.0

283

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

7.0

110

637

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

7.0

128

773

HA1RA, ,

SPAT

0.4

7.0

781

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.7

6.9

110

638

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.8

6.9

102

579

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

6.3

6.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

6.9

1416

12399

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

6.9

792

6561

RL130, ,

NOMESCO Finland

5.4

6.9

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

6.9

119

SPAT1167

SPAT

Insertion of urinary catheter

1.5

6.9

199

1338

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.1

6.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

6.9

422

3234

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.1

6.8

313

J01CF02

ATC

cloxacillin; systemic

1.7

6.8

110

642

3459X

ICD-9 Finland

Epilepsy, unspecified

4.1

6.8

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

6.7

6.8

ZX114

NOMESCO Finland

Intramuscular

2.2

6.8

241

R41.3

ICD-10 Finland

Other amnesia

1.6

6.8

168

1092

G41.1

ICD-10 Finland

Petit mal status epilepticus

16.7

6.7

A11CC03

ATC

alfacalcidol; systemic

1.7

6.7

117

697

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.1

6.7

308

Z08

ICPC

Social welfare problem

2.3

6.7

223

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

6.7

381

2887

P16

ICPC

Acute alcohol abuse

2.2

6.7

249

S72.0

ICD-10 Finland

Fracture of neck of femur

1.4

6.7

284

2055

ZY000

NOMESCO Finland

Hospital inpatient

2.4

6.7

168

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

6.7

1503

13264

UKC02

NOMESCO Finland

Cystoscopy

1.2

6.6

976

8291

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.3

6.6

193

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

6.6

441

3419

I65.1

ICD-10 Finland

Occlusion and stenosis of basilar artery

7.8

6.6

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

2.6

6.6

145

RS390, ,

NOMESCO Finland

12.2

6.6

RS230, ,

NOMESCO Finland

2.9

6.6

100

SPAT1240

SPAT

Therapeutic discussion

1.4

6.6

277

2002

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

1.9

6.5

380

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

8.7

6.5

Y94.0

ICD-10 Finland

Accident at home

1.8

6.5

100

575

2152

FHL

Extraction, big brain

6.8

6.5

OAB95, ,

SPAT

0.4

6.5

910

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

6.4

328

2444

N05AD01

ATC

haloperidol; systemic

1.5

6.4

178

1186

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

6.4

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.1

6.4

274

R5110, ,

SPAT

1.3

6.4

436

3393

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.1

6.3

N03AX12

ATC

[U] gabapentin; oral

1.2

6.3

682

5609

N74

ICPC

Malignant neoplasm nervous system

6.5

6.3

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

8.1

6.3

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

6.3

172

1143

G81.0

ICD-10 Finland

Flaccid hemiplegia

11.0

6.3

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.5

6.3

C09CA01

ATC

losartan; oral

1.2

6.3

1329

11660

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

3.2

6.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.3

379

2900

N06AX16

ATC

venlafaxine; oral

1.3

6.2

435

3393

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.6

6.2

136

859

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

2.8

6.2

103

RT152, ,

NOMESCO Finland

26.7

6.2

L57.0

ICD-10 Finland

Actinic keratosis

0.8

6.2

428

5435

C07AB08

ATC

celiprolol; oral

1.5

6.2

153

996

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.7

6.1

111

669

R01AD59

ATC

mometasone, combinations; nasal

0.5

6.1

1065

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.0

6.1

285

R053, ,

ICD-10 Finland

0.4

6.1

664

M05BA04

ATC

alendronic acid; oral

1.3

6.1

492

3910

ZX120

NOMESCO Finland

Intravenous

1.3

6.1

414

3217

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.6

6.1

125

778

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.6

6.1

118

724

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.5

6.1

139

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.1

6.1

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

3.8

6.1

NG4AD

NOMESCO Finland

Lower leg CT

3.8

6.1

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

6.1

1100

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

6.1

819

9654

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

1.6

6.1

117

718

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

8.6

6.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

6.0

131

827

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

6.0

105

R1420, ,

SPAT

2.8

6.0

105

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

10.0

6.0

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

6.7

6.0

G72.8

ICD-10 Finland

Other specified myopathies

1.7

6.0

530

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3018

14885

3.04

307.65

2.9

2.1

236.22

251.36

u/l

0.34

2939

13765

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2103

6870

4.15

307.65

2.5

2.0

29.18

30.25

11.99

2061

6643

(3036489) Thrombin time

589

1293

4.94

251.82

2.3

2.1

20.99

21.70

1.65

552

1165

(3032080) INR in Blood by Coagulation assay

3612

25909

1.97

138.40

20.1

18.8

1.36

inr

0.08

3161

21768

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

230

384

6.18

131.72

2.8

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

135

124

11.11

126.82

2.6

2.3

53.49

49.76

umol/l

0.44

108

102

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1612

8954

2.09

126.50

3.6

3.1

0.81

0.82

mmol/l

0.28

1532

8310

(3009466) Valproate [Moles/volume] in Serum or Plasma

250

516

5.01

113.67

3.7

4.7

336.08

332.23

umol/l

0.14

213

449

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

418

1284

3.42

110.78

3.0

2.3

3.59

g/l

0.01

410

1227

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

372

1090

3.57

105.98

3.1

2.5

192.92

209.94

2.84

366

1025

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

157

247

6.50

95.25

1.9

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

369

1151

3.35

95.20

2.9

2.3

92.35

88.37

2.51

364

1110

(3019977) pH of Arterial blood

1250

6942

2.01

94.46

10.7

6.8

7.42

0.25

752

3827

(3003396) Base excess in Arterial blood by calculation

1246

6936

2.00

93.42

10.6

6.7

1.23

0.96

mmol/l

1.50

1023

5630

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1240

6972

1.98

89.95

10.8

6.8

5.10

5.07

kpa

0.46

1188

6665

(3027801) Oxygen [Partial pressure] in Arterial blood

1239

6970

1.98

89.72

10.8

6.8

12.51

11.86

kpa

3.80

1189

6658

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

295

833

3.67

88.66

2.5

1.4

17183.43

953.60

e6/l

0.69

233

656

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

293

828

3.67

87.95

2.5

1.4

93.22

36.73

e6/l

0.72

227

612

(3023368) Bacteria identified in Blood by Culture

2406

16902

1.70

82.14

5.0

4.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3794

30162

1.68

79.65

8.5

5.0

7.09

6.89

mmol/l

6.21

3691

28623

(3033658) Prothrombin time (PT) actual/Normal

1857

12247

1.74

79.14

5.7

4.2

82.00

84.06

3.06

1817

11984

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1252

7398

1.87

76.77

6.6

5.8

1.01

1.05

mmol/l

4.39

1175

6789

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

120

179

6.82

76.57

3.2

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1013

5682

1.94

72.42

12.2

7.5

120.80

119.67

g/l

0.97

996

5549

(3016502) Oxygen saturation in Arterial blood

1081

6237

1.89

70.79

11.4

7.0

95.52

95.18

0.87

1044

6002

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

8.39

66.75

1.2

85.59

87.30

0.14

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

291

980

3.07

65.81

2.1

1.3

815.71

599.15

mg/l

1.73

275

926

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

12.15

65.06

2.1

4.1

45.19

39.45

umol/l

0.77

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

109

8.08

64.73

1.2

1.4

86.21

87.82

0.11

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

138

7.12

64.65

3.2

2.9

31.17

29.31

umol/l

0.72

101

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1545

10162

1.70

63.99

2.2

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

297

1077

2.85

58.77

3.0

2.6

32.72

34.85

umol/l

0.71

269

951

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

256

857

3.07

58.45

1.9

1.3

3.90

3.79

mmol/l

0.68

238

805

(3020191) Ethanol [Moles/volume] in Serum or Plasma

133

289

4.68

56.81

1.6

1.3

1.01

0.98

promille

0.07

231

(3026008) Bacteria identified in Urine by Culture

2330

17394

1.55

55.56

4.1

3.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3118

24812

1.53

55.20

9.7

6.6

1.20

1.21

mmol/l

14.70

2923

22652

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

9.64

54.77

1.2

1.3

74.92

81.28

0.34

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

9.50

54.17

1.2

1.3

81.14

84.50

0.12

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1188

7626

1.69

52.44

2.1

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3379

27685

1.50

49.70

10.5

7.2

1.20

1.21

mmol/l

9.56

2976

23609

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1106

7085

1.69

48.82

2.1

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

429

2015

2.21

48.74

3.6

2.5

0.36

0.33

iu/ml

0.93

252

1065

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

648

3548

1.92

48.52

12.3

8.5

24.43

24.24

mmol/l

0.75

629

3426

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2665

20930

1.49

47.59

5.2

4.2

74.97

106.45

ng/l

0.50

2285

16298

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

845

5091

1.77

46.36

2.4

6.48

7.06

ug/l

0.47

726

4309

(3008152) Bicarbonate [Moles/volume] in Arterial blood

659

3731

1.86

44.31

10.8

6.2

24.70

24.45

mmol/l

0.88

631

3578

(3023410) Appearance of Cerebral spinal fluid

132

346

3.88

44.15

3.0

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

417

2042

2.12

42.51

2.4

2.1

597.74

735.78

ug/l

0.34

401

1951

(3020779) Urea [Moles/volume] in Serum or Plasma

882

5518

1.70

41.96

8.9

6.5

9.61

11.52

mmol/l

11.11

837

5219

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

119

304

3.97

41.27

2.1

1.2

2.80

2.21

mmol/l

2.28

102

286

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

637

3646

1.83

41.23

12.0

7.6

24.45

24.81

mmol/l

1.67

629

3619

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1492

10719

1.52

39.46

4.8

4.2

279.68

532.78

ng/l

1.76

1326

9313

(3044640) Blood type and Crossmatch panel - Blood

2139

16621

1.44

37.64

2.9

2.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

830

5317

1.65

35.65

11.0

6.7

1.38

1.39

mmol/l

0.12

808

5192

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

569

3294

1.80

35.26

13.5

9.1

15.99

15.81

0.83

549

3181

(3000991) Gas panel - Venous blood

794

5090

1.64

33.89

12.7

7.9

—

(3018418) pH of Serum or Plasma

2100

16637

1.40

31.67

5.1

4.3

7.40

1.72

1575

11941

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1656

12587

1.43

31.61

2.8

2.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

373

1954

1.97

31.45

6.1

3.7

1.44

1.43

mmol/l

0.02

366

1920

(3003181) Sodium [Moles/volume] in Urine

244

1092

2.29

31.04

1.5

1.3

77.05

61.22

mmol/l

5.05

200

874

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

523

3070

1.77

30.79

1.6

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

191

773

2.52

30.41

6.1

5.7

11.66

12.29

mg/l

0.86

175

710

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

177

4.33

29.88

1.8

1.2

51.15

68.80

1.34

(3012544) pH of Venous blood

912

6251

1.54

28.96

4.7

3.7

7.38

1.37

588

3675

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2737

22863

1.36

28.92

3.2

2.9

—

estimate

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

898

6179

1.53

27.93

4.7

3.6

5.89

5.82

kpa

1.18

874

6018

(3002032) Base excess in Venous blood by calculation

875

6011

1.53

27.37

4.7

3.7

1.87

1.73

mmol/l

0.54

780

5200

(1761868) Lipid panel - Serum or Plasma

1031

13892

0.69

25.12

3.6

3.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1398

17874

0.72

25.10

2.0

1.9

1.35

1.32

mmol/l

0.47

1198

14604

(3026782) Osmolality of Urine

1444

11094

1.40

24.86

3.5

3.1

534.35

535.67

mosm/kgh2o

0.08

1300

9694

(3024354) Oxygen [Partial pressure] in Venous blood

750

5155

1.52

23.15

4.2

3.1

4.69

4.37

kpa

3.43

729

5012

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

444

2697

1.70

22.98

7.6

4.5

1.56

1.58

0.17

420

2559

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

126

478

2.67

22.97

1.4

1.2

2.97

3.47

u/ml

0.20

159

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

3.59

22.80

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3741

33359

1.31

22.51

6.5

5.3

1838.05

2426.72

e6/l

0.38

558

(3007930) Methemoglobin/Hemoglobin.total in Blood

411

2473

1.71

22.02

8.0

4.7

0.90

0.86

1.24

391

2340

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

459

2.62

21.02

1.4

1.2

3.83

3.84

u/ml

0.00

209

(3019309) Folate [Moles/volume] in Red Blood Cells

1422

11203

1.35

20.26

1.8

1162.98

1156.07

nmol/l

0.10

1104

8286

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

571

3825

1.54

19.72

1.9

1.7

—

(3008295) Osmolality of Serum or Plasma

138

593

2.36

19.40

1.5

1.3

281.98

274.82

mosm/kgh2o

2.82

107

429

(3004119) Hemoglobin [Mass/volume] in Venous blood

564

3784

1.54

19.33

4.2

3.1

126.99

127.03

g/l

0.02

552

3679

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.30

19.15

1.1

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

446

2856

1.61

18.71

4.1

3.3

25.51

25.11

mmol/l

1.94

432

2771

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1314

10382

1.34

18.06

2.4

1.7

1.66

1.61

mg/l

0.21

1079

8160

(3020891) Body temperature

432

2782

1.59

17.70

7.1

4.2

36.89

36.92

°c

0.56

426

2749

(4198724) Urine methamphetamine measurement

4.89

17.52

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

4.17

17.39

1.5

1.1

—

(4195642) Thrombophilia screening test

103

408

2.55

17.31

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

608

4247

1.48

17.12

1.8

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

122

2619

0.45

17.09

1.7

2.1

3.42

3.50

ratio

0.31

100

2114

(3047181) Lactate [Moles/volume] in Blood

286

1671

1.75

17.03

9.6

5.3

1.45

1.38

mmol/l

0.37

251

1489

(3002582) Erythrocytes [#/volume] in Urine

2130

18114

1.27

16.54

4.4

3.6

89.99

112.10

e6/l

0.51

1744

14002

(3010375) cycloSPORINE [Mass/volume] in Blood

149

3.58

16.22

33.6

28.1

105.54

117.38

ug/l

0.71

126

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

506

3444

1.51

16.16

4.0

3.7

1.95

2.00

mmol/l

0.10

355

2515

(4268621) Lupus anticoagulant assay

331

2.65

15.89

2.4

2.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

105

441

2.40

15.61

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

1548

12724

1.29

15.61

3.4

2.8

4.96

4.75

e6/l

0.29

1441

11528

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

125

3.78

15.60

1.5

1.2

24.15

24.00

0.01

(3036481) Cortisol [Moles/volume] in Serum or Plasma

598

4259

1.45

15.18

2.2

2.3

390.88

383.65

nmol/l

0.38

553

3917

(36304419) Bacteria [Presence] in Urine

1754

14707

1.27

14.96

4.2

3.4

0.00

179.72

estimate

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1792

15065

1.27

14.95

4.1

3.2

36.71

37.32

u/l

0.12

1679

14048

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

199

3.09

14.79

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.34

14.53

1.0

1.3

—

mmol/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1866

0.41

14.44

1.6

1.8

3.27

3.42

mmol/l

0.50

1350

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

459

3135

1.50

14.40

4.7

4.0

49.43

45.64

2.53

451

3085

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

402

2674

1.54

14.28

2.3

1.8

2.89

2.40

ug/l

0.18

333

2320

(3009343) pH of Capillary blood

549

3895

1.45

14.20

4.1

3.9

7.41

7.42

0.50

471

3246

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

6.69

14.01

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

306

1923

1.62

13.88

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2786

24751

1.23

13.84

6.2

5.0

33.60

34.62

g/l

17.08

2593

22918

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3061

27487

1.23

13.64

4.4

3.3

67.89

56.74

u/l

4.42

2895

24941

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4080

43604

0.80

13.49

5.4

5.6

6.17

6.10

mmol/l

2.27

3681

38855

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

558

4010

1.43

13.45

4.1

3.9

5.17

5.18

kpa

0.06

522

3788

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4021

43033

0.81

13.42

26.4

19.3

74.90

72.60

ml/min/173m2

9.07

3795

40118

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4021

43018

0.81

13.28

5.2

4.21

4.47

mmol/l

50.31

3736

38891

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3978

42605

0.81

13.27

5.1

1.38

1.44

mmol/l

11.62

3682

38216

(3039000) Anion gap in Blood by calculation

203

1158

1.78

13.20

11.7

6.1

11.12

11.42

mmol/l

0.53

185

1035

(3018572) Chloride [Moles/volume] in Blood

203

1158

1.78

13.20

11.7

6.1

104.37

104.93

mmol/l

0.77

185

1036

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

166

3.15

13.11

1.3

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

352

2.43

13.10

1.0

1.1

—

47.99

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4145

44181

0.81

13.09

5.9

6.0

2.36

2.58

mmol/l

45.74

3834

39823

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

695

5221

1.37

12.92

2.5

2.1

0.20

g/l

0.06

645

4801

(3030467) Casts [#/volume] in Urine by Automated count

1833

15658

1.24

12.89

4.3

3.5

0.47

0.49

e6/l

0.10

1473

11700

(3007853) Bacteria identified in Skin by Aerobe culture

795

6107

1.35

12.80

1.9

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

487

3452

1.45

12.64

4.9

3.8

24.21

24.06

mmol/l

0.49

477

3402

(3011985) Renin [Units/volume] in Plasma

126

632

2.01

12.18

1.3

1.4

51.80

67.19

mu/l

0.36

115

557

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

326

2148

1.55

12.11

2.0

1.8

—

(40768804) Tissue Pathology biopsy report

1631

18983

0.81

11.82

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

238

1468

1.65

11.68

3.7

3.4

2.14

1.88

index

0.18

117

755

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

343

2306

1.52

11.62

2.1

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

118

589

2.02

11.59

1.4

1.3

284.56

278.73

pmol/l

0.07

103

493

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

531

3902

1.39

11.25

2.0

1.7

1.76

1.55

4.44

442

3288

(3028626) Oxygen [Partial pressure] in Capillary blood

248

1568

1.61

11.03

3.9

3.2

8.13

7.85

kpa

1.76

237

1533

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

375

2.26

10.99

1.0

1.1

—

2.42

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3018

27413

1.20

10.87

7.5

6.5

12.18

12.68

umol/l

1.11

2881

26043

(3026250) Tacrolimus [Mass/volume] in Blood

144

3.07

10.70

43.7

35.9

7.03

7.34

ug/l

0.37

126

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1027

12474

0.79

10.70

3.2

3.5

0.90

0.83

ug/l

0.74

746

8826

(3014271) Vancomycin [Susceptibility]

348

2.29

10.68

3.0

—

(3018095) Leukocytes [#/volume] in Urine

2240

19831

1.20

10.54

5.2

4.2

140.98

118.40

e6/l

0.42

1766

14394

(3042936) Bacteria identified in Isolate by Culture

965

7815

1.28

10.43

2.3

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4031

42767

0.83

10.28

7.3

7.2

40.95

40.35

mmol/mol

3.24

3703

38994

(3042733) HLA Ab [Presence] in Serum

108

3.35

10.10

5.4

4.5

—

(3034426) Prothrombin time (PT)

3.61

10.06

1.3

31.55

28.47

0.98

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1086

8984

1.25

9.77

3.8

3.4

2.18

2.19

e6/l

0.03

610

4547

(3028271) Lactate [Moles/volume] in Capillary blood

159

925

1.74

9.76

2.1

1.9

1.91

1.70

mmol/l

1.37

143

905

(3028707) Methadone [Presence] in Urine by Screen method

263

2.41

9.65

3.0

2.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3639

33801

1.19

9.64

5.9

4.9

2.32

2.25

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

328

2.24

9.47

2.2

—

(3016038) Potassium [Moles/volume] in Urine

402

2.10

9.32

1.2

1.1

32.02

34.97

mmol/l

0.61

334

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1162

9750

1.24

9.14

3.6

3.2

1.16

1.13

e6/l

0.09

686

5325

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

191

2.58

8.71

1.6

1.5

63.80

119.65

umol/l

1.38

111

(3011397) Hemoglobin [Presence] in Urine by Test strip

1410

12125

1.21

8.66

4.5

4.0

0.20

0.46

0.38

174

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1864

16461

1.19

8.56

3.1

2.6

60.64

60.74

u/l

0.02

1738

15151

(3024932) HLA-DR beta [Type]

105

3.15

8.47

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.16

8.44

1.2

—

u/ml

—

(21494755) Public health laboratory ask at order entry panel

105

1871

0.55

8.42

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

124

705

1.77

8.31

11.5

6.3

7.85

7.29

mmol/l

0.55

109

564

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

719

5774

1.28

8.23

3.4

2.7

10.06

10.04

umol/l

0.01

640

5044

(3024471) HLA-A [Type]

108

3.07

8.10

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

152

2.71

8.06

1.1

1.08

1.09

ratio

0.20

117

(40767503) Oxygen content in Capillary blood by calculation

197

1274

1.56

8.06

3.0

2.8

16.66

15.83

3.30

180

1253

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

648

5151

1.29

8.04

3.7

3.1

239.65

257.09

ng/l

0.49

589

4728

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4512

47084

0.84

8.00

15.1

12.7

25.83

25.22

u/l

0.42

4357

45202

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

193

1247

1.57

7.93

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

1247

1.57

7.93

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

204

1335

1.55

7.92

3.5

3.1

89.81

88.62

1.62

194

1302

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.43

7.88

4.6

2.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

217

1445

1.52

7.79

2.4

2.3

132.52

126.10

g/l

2.77

160

1115

(3001019) Free T4 and TSH panel - Serum or Plasma

1036

0.43

7.75

1.5

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

3.03

7.71

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

136

2203

0.61

7.61

1.2

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.14

7.52

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.30

7.50

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

744

1.71

7.44

3.7

2.5

1794.20

2026.02

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

109

2.95

7.36

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

526

1.84

7.31

1.6

1.3

—

nmol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

10.85

7.28

1.2

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

173

2.50

7.22

2.7

0.61

mmol/l

0.15

173

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

530

1.82

7.15

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

714

5828

1.25

7.11

4.9

3.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1719

15280

1.17

7.02

2.4

3.15

2.99

mg/l

1.31

1463

13018

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

512

1.83

7.00

2.9

3.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

310

2.08

6.98

1.0

1.1

—

(3022145) Colonoscopy Study observation

427

5501

0.76

6.88

1.3

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

115

678

1.71

6.86

1.6

1.4

147.14

154.58

au/ml

0.28

208

(3015736) pH of Urine

2295

20890

1.16

6.85

4.2

3.8

6.37

6.26

4.77

1206

11361

(3027315) Oxygen [Partial pressure] in Blood

187

1242

1.52

6.84

4.7

4.6

8.30

8.31

kpa

0.05

178

1214

(3007461) Platelets [#/volume] in Blood

4659

48327

0.85

6.82

39.8

28.7

237.41

239.97

e9/l

1.69

4543

46995

(3008037) Lactate [Moles/volume] in Venous blood

230

1595

1.46

6.81

3.8

3.3

1.85

1.68

mmol/l

1.35

220

1550

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

112

657

1.72

6.81

1.4

1.2

286.67

287.23

u/ml

0.01

390

(3026361) Erythrocytes [#/volume] in Blood

4660

48333

0.85

6.79

39.8

28.7

4.29

4.39

e12/l

29.67

4533

46800

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4660

48332

0.85

6.78

41.0

29.2

38.58

39.56

24.57

4592

47498

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4660

48331

0.85

6.78

39.7

28.6

91.84

91.76

0.61

4593

47518

(3035941) MCH [Entitic mass]

4660

48330

0.85

6.77

39.7

28.6

30.48

30.43

1.05

4592

47518

(3010813) Leukocytes [#/volume] in Blood

4661

48339

0.85

6.77

39.8

28.7

7.30

6.95

e9/l

13.56

4537

46796

(3000963) Hemoglobin [Mass/volume] in Blood

4661

48338

0.85

6.76

40.1

28.9

129.39

132.52

g/l

35.63

4601

47549

(3015235) Bicarbonate [Moles/volume] in Capillary blood

298

2170

1.39

6.73

3.4

3.1

24.72

24.92

mmol/l

0.39

287

2134

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

115

2.79

6.72

1.0

1.1

—

(3012501) Base excess in Blood by calculation

185

1234

1.51

6.65

4.7

4.6

2.45

2.77

mmol/l

0.78

123

837

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1512

17016

0.85

6.64

4.5

4.9

23.01

22.34

0.88

752

9169

(3013290) Carbon dioxide [Partial pressure] in Blood

185

1235

1.51

6.62

4.7

4.6

4.99

kpa

0.03

176

1208

(3044242) Glucose [Moles/volume] in Arterial blood

359

1.96

6.55

1.7

2.0

8.18

8.30

mmol/l

0.11

359

(3019150) Specific gravity of Urine by Refractometry

1324

11575

1.18

6.55

5.2

4.5

1.02

1.15

kg/l

0.50

929

7833

(3024928) Oxygen saturation in Venous blood

210

1444

1.47

6.51

4.0

2.8

63.87

59.31

1.98

196

1390

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

539

1.77

6.50

1.5

1.3

0.19

0.20

nmol/l

0.56

440

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3881

40773

0.87

6.48

4.5

4.4

1.27

1.28

mmol/l

0.40

3557

36058

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

342

1.97

6.37

2.4

2.3

34.17

32.05

iu/ml

—

(44806118) Parainfluenza type 4 nucleic acid detection

108

640

1.70

6.35

1.9

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

108

640

1.70

6.35

1.9

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

108

640

1.70

6.35

1.9

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

108

640

1.70

6.35

1.9

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

493

1.80

6.30

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1919

21142

0.86

6.29

5.3

6.1

6.62

4.05

ug/l

0.44

1707

18834

(3010421) pH of Blood

260

1874

1.40

6.26

4.7

4.0

7.41

0.94

252

1848

(3039443) Prostate specific Ag panel - Serum or Plasma

770

0.41

6.23

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1680

15026

1.16

6.21

5.2

4.4

0.00

estimate

1.54

513

5018

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

125

776

1.62

6.17

1.6

1.4

—

(3022313) Gas panel - Capillary blood

358

2723

1.33

6.16

4.2

4.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

206

1428

1.46

6.15

1.8

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

498

3966

1.28

6.10

1.9

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.46

5.99

1.0

1.2

—

(3001604) Monocytes [#/volume] in Blood

2659

24618

1.14

5.97

6.5

5.9

0.64

0.63

e9/l

1.93

2288

20609

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

958

1.55

5.92

7.0

5.0

1074.64

2917.76

iu/ml

0.46

146

(3006315) Basophils [#/volume] in Blood

2669

24730

1.14

5.89

6.5

5.9

0.04

e9/l

3.20

2300

20728

(3006504) Eosinophils/Leukocytes in Blood

2482

22893

1.14

5.86

7.1

6.2

2.68

2.85

3.09

2345

21190

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

113

2.66

5.81

1.7

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

376

4813

0.77

5.78

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

577

7010

0.80

5.73

1.2

1.3

23.62

13.52

u/ml

0.51

206

2423

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.79

5.71

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

116

722

1.62

5.70

1.4

1.2

—

119.20

—

(3017569) Oxygen content in Arterial blood

364

1.88

5.66

1.7

2.3

15.65

16.01

0.37

364

(3019069) Monocytes/Leukocytes in Blood

2484

22948

1.14

5.66

7.1

6.3

9.25

9.15

0.84

2349

21228

(3015377) Calcium [Moles/volume] in Serum or Plasma

2049

18694

1.14

5.63

3.7

3.5

2.34

2.35

mmol/l

1.83

1833

16721

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

2.70

5.58

1.0

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

2706

25159

1.14

5.55

6.7

6.0

1.77

1.86

e9/l

1.01

2370

21590

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

229

2.10

5.53

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

111

2.62

5.46

1.7

2.0

—

(3022096) Basophils/Leukocytes in Blood

2477

22918

1.14

5.45

7.1

6.3

0.61

0.65

3.61

2344

21216

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

2.60

5.37

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

224

3051

0.72

5.31

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

107

2.62

5.30

1.4

1.3

—

(1616796) Gas panel - Central venous blood

194

1371

1.43

5.28

4.1

4.0

—

(3018010) Neutrophils/Leukocytes in Blood

2456

22746

1.13

5.27

6.9

6.1

60.50

58.81

9.42

2361

21502

(3038515) Glucose [Moles/volume] in Venous blood

194

1375

1.42

5.20

4.0

3.4

8.00

7.88

mmol/l

0.21

188

1339

(3035350) Ketones [Presence] in Urine by Test strip

2804

26197

1.13

5.20

4.9

4.3

8.72

4.75

estimate

0.42

633

5831

(3004451) EKG impression Narrative

339

1.87

5.20

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

5.15

1.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

281

2121

1.34

5.14

4.6

4.1

24.77

24.81

mmol/l

0.06

254

1908

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4646

47955

0.87

5.12

35.0

25.6

84.62

85.15

umol/l

0.30

4579

47114

(3014148) Varicella zoster virus Ab [Titer] in Serum

348

1.85

5.12

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

324

4156

0.77

5.08

2.4

2.2

11.17

12.54

nmol/l

2.20

268

3647

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.76

5.08

2.0

2.2

18.99

17.64

umol/l

0.14

(3013115) Eosinophils [#/volume] in Blood

2722

25415

1.13

5.05

6.8

6.1

0.19

0.20

e9/l

1.76

2367

21597

(3002256) Pathology report gross observation

577

6913

0.82

5.00

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

882

7611

1.19

4.99

2.7

2.4

1.85

1.77

1.24

773

6660

(3021601) Nitrite [Presence] in Urine by Test strip

2765

25855

1.13

4.98

4.9

4.2

0.00

estimate

1.34

614

5623

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

198

1422

1.41

4.95

1.8

1.5

—

(3002030) Lymphocytes/Leukocytes in Blood

2503

23274

1.13

4.93

7.1

6.3

24.00

25.81

13.24

2382

21829

(40768446) Kidney Pathology biopsy report

148

2.30

4.92

2.1

1.5

—

(40768793) Breast Pathology biopsy report

962

0.54

4.91

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

575

4779

1.22

4.86

2.6

2.5

36.85

48.56

u/l

0.56

491

4013

(3007566) Smooth muscle Ab [Titer] in Serum

164

1144

1.45

4.82

1.3

1.2

68.46

103.98

titre

1.51

103

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

4.63

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

551

4583

1.22

4.63

1.9

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.21

4.60

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1294

11576

1.15

4.58

3.1

3.2

2.46

2.47

mmol/l

0.28

1127

10300

(3009261) Glucose [Presence] in Urine by Test strip

2806

26343

1.12

4.58

5.0

4.3

0.02

0.07

estimate

0.43

595

5434

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

550

4580

1.22

4.57

5.1

4.1

1.22

1.23

mmol/l

1.14

491

3869

(40768800) Prostate Pathology biopsy report

1511

0.64

4.57

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

826

7146

1.18

4.53

4.8

4.1

253.49

249.48

u/l

0.26

773

6705

(1001926) Buprenorphine [Presence] in Urine by Screen method

455

1.68

4.43

2.6

2.0

—

(3034770) Mitochondria Ab [Titer] in Serum

163

1156

1.42

4.42

1.2

690.00

1037.57

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

200

1470

1.37

4.40

2.2

1.6

0.49

0.32

mg/l

2.70

105

665

(3022806) Fractional oxyhemoglobin in Capillary blood

108

707

1.54

4.37

1.9

88.62

88.94

0.21

700

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

163

2.15

4.35

1.1

1.14

1.18

u/l

0.18

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

4.31

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

646

7553

0.84

4.31

1.2

1.3

56.60

38.85

iu/ml

0.79

180

2259

(3030981) Hyaline casts [#/volume] in Urine by Automated count

563

4736

1.21

4.23

2.9

2.6

0.48

0.53

e6/l

0.24

547

4577

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

390

3158

1.25

4.22

1.6

1.7

1.51

1.56

g/l

0.37

330

2702

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

292

3698

0.78

4.18

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

495

1.62

4.13

3.5

3.2

11.19

12.07

index

0.31

242

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

2.04

4.12

1.9

2.3

5.33

4.86

kpa

2.06

187

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

188

2.03

4.07

1.9

2.3

10.84

10.26

kpa

0.21

188

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

8.01

4.05

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1133

10131

1.15

4.00

3.1

2.6

11.40

12.04

umol/l

2.53

1032

9292

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.48

3.95

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

329

2637

1.26

3.91

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

325

4029

0.80

3.91

1.3

1.4

—

(3024316) Viscosity of Plasma

4.79

3.86

2.4

1.8

1.59

1.77

mpas

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

220

1.91

3.85

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

215

1641

1.32

3.74

2.1

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2934

27822

1.10

3.65

9.7

9.3

4.52

4.36

e9/l

2.59

2557

23783

(3011288) Drugs identified in Urine by Screen method Nominal

388

1.66

3.63

4.7

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

152

1106

1.38

3.62

1.4

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

168

1246

1.36

3.56

2.0

1.5

0.24

g/l

0.39

162

1178

(3016879) Cocaine [Presence] in Urine

547

1.54

3.55

2.9

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

771

0.57

3.55

1.2

1.54

1.50

g/l

0.38

771

(4094501) Cardiovascular stress test using bicycle ergometer

1247

0.66

3.51

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

287

1.75

3.47

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

698

0.56

3.41

1.2

0.63

0.64

ratio

—

106

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.34

3.40

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.75

3.38

3.8

3.5

—

(3041354) Potassium [Moles/volume] in Venous blood

113

791

1.44

3.38

2.6

2.4

4.05

4.12

mmol/l

1.29

113

782

(3035285) Chloride [Moles/volume] in Venous blood

113

791

1.44

3.38

2.6

2.4

105.15

105.41

mmol/l

0.25

113

782

(3033705) Calcium.ionized [Moles/volume] in Venous blood

111

775

1.44

3.37

2.6

2.4

1.20

mmol/l

0.18

111

766

(40768797) Stomach Pathology biopsy report

589

6796

0.85

3.36

1.3

—

(3027008) Opiates [Presence] in Urine

593

1.49

3.21

2.8

2.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

5.34

3.19

3.1

2.1

0.07

0.10

ug/l

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

6.37

3.18

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

596

1.48

3.14

2.8

2.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.41

3.13

14.1

13.3

5.56

5.16

mmol/l

0.17

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

169

1285

1.32

3.09

2.0

1.5

1.21

1.17

g/l

0.66

163

1215

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.80

3.08

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

591

1.48

3.07

2.8

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1053

9530

1.13

3.05

3.2

2.6

2.18

2.25

g/l

3.14

955

8699

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

345

1.63

3.04

1.9

1.7

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

174

1.90

3.03

1.3

0.53

ratio

0.01

106

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

346

1.62

3.01

1.2

242.86

116.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

346

1.62

3.01

1.2

115.00

117.12

titre

—

(3012516) Albumin [Mass/volume] in Urine

1669

17916

0.91

3.00

3.6

3.5

88.49

51.57

mg/l

4.18

1174

11618

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1074

0.67

2.99

1.7

4.98

5.26

mg/l

0.05

812

(3003694) ABO and Rh group [Type] in Blood

1335

12262

1.11

2.98

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

332

1.63

2.96

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4027

41509

0.91

2.95

5.3

5.2

1.99

2.05

mu/l

1.51

3696

37287

(3024891) Influenza virus A+B Ag [Presence] in Specimen

143

1069

1.35

2.95

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

983

8885

1.13

2.91

3.2

2.7

21.45

21.55

0.08

903

8158

(3021960) Folate [Moles/volume] in Serum or Plasma

1791

16719

1.10

2.90

1.8

19.17

19.95

nmol/l

1.19

1584

13996

(3002079) Sodium [Moles/time] in 24 hour Urine

170

1.89

2.89

1.3

1.2

128.69

172.24

mmol/24h

2.33

170

(40758292) HTLV I+II Ab panel - Serum

2.43

2.87

1.2

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.64

2.79

6.9

4.7

64.57

61.45

ug/min

0.04

(3048929) Epstein Barr virus Ab [Presence] in Serum

126

933

1.36

2.78

1.4

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

674

5964

1.15

2.78

2.8

2.5

70.21

67.67

e9/l

0.86

486

4409

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

681

1.42

2.74

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

1206

1.31

2.71

1.6

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

265

1.66

2.65

1.3

1.2

78.00

87.15

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

206

1.75

2.60

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

923

0.67

2.60

2.1

1.9

181.32

204.31

pmol/l

0.95

866

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

554

6292

0.87

2.59

3.4

4.2

17.55

27.12

ug/l

0.55

467

5238

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

147

1899

0.77

2.58

3.8

4.0

278.35

90.77

u/ml

0.45

142

1826

(3016650) Hepatitis A virus Ab [Presence] in Serum

648

1.41

2.57

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.46

2.54

1.0

1.2

—

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.46

2.54

3.0

5.0

—

(3037121) Protein [Mass/volume] in Urine

234

1908

1.24

2.51

2.7

3.2

325.83

400.92

mg/l

0.59

125

825

(3008757) Leukocyte morphology finding [Identifier] in Blood

584

1.43

2.51

3.7

4.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

152

1183

1.29

2.42

1.7

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

399

1.51

2.42

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

160

0.31

2.40

1.6

1.9

0.00

0.04

estimate

—

160

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

167

1.80

2.39

1.1

1516.74

385.47

ng/l

0.42

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

508

4460

1.15

2.37

4.8

3.8

110.45

96.34

ng/l

1.98

417

3740

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2048

19379

1.09

2.37

5.2

4.4

0.98

0.16

estimate

0.40

524

4635

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.25

2.37

3.2

2.6

—

(3042517) Benzodiazepines panel - Urine

4.12

2.36

1.4

1.6

—

(3027944) Amphetamines [Presence] in Urine

585

1.41

2.32

2.8

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

229

1.66

2.32

15.4

2.1

59.16

67.56

mg/l

0.51

156

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.22

2.30

3.4

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

404

1.49

2.30

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

124

1600

0.77

2.21

1.8

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.86

2.20

1.2

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

2.17

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

158

1.78

2.16

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

198

1615

1.23

2.16

3.4

3.3

0.80

0.82

nmol/l

0.43

148

1282

(3044009) aPTT.lupus sensitive (LA screen)

3.69

2.15

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

1045

1.29

2.14

1.5

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.78

2.13

1.1

1.2

16.20

11.61

u/l

—

(3008898) HLA-B27 [Presence]

988

0.72

2.12

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

138

1743

0.79

2.09

1.8

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

401

3500

1.16

2.07

2.5

2.9

10.88

10.71

g/l

0.29

367

3198

(3009508) Creatinine [Moles/volume] in Urine

1730

18281

0.92

2.05

3.6

3.4

7.00

7.24

mmol/l

1.52

1449

15067

(3017732) Neutrophils [#/volume] in Blood

529

5923

0.88

2.04

3.2

3.3

5.20

4.86

e9/l

0.24

439

4918

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

104

1.93

1.99

1.4

1.2

—

(4034850) Laboratory test

185

1514

1.23

1.99

12.0

11.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1743

18392

0.93

1.98

4.3

4.2

17.56

9.29

mg/mmol

4.53

1186

11564

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

109

839

1.30

1.95

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

1.94

1.1

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.75

1.93

3.3

2.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

242

1.57

1.92

1.1

388.03

301.34

mg/l

1.22

207

(3023419) Bacteria identified in Sputum by Culture

747

1.32

1.89

1.9

2.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

158

1.71

1.88

1.0

1.1

1584.37

1628.65

miu/ml

0.07

158

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3503

36023

0.93

1.88

33.8

23.6

14.04

13.92

5.05

3460

35474

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.18

1.88

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

244

1.56

1.86

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.39

1.85

2.1

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

350

1.46

1.84

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.53

1.83

1.3

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

101

1301

0.77

1.83

1.7

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1271

11915

1.08

1.81

1.8

34294391.15

25523664.48

pmol/l

0.17

1041

9556

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

885

1.28

1.80

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

184

1524

1.21

1.79

1.5

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

562

6215

0.89

1.78

5.0

5.1

33.79

33.04

0.78

415

3760

(3020393) Adenovirus Ag [Presence] in Stool

2.34

1.77

1.9

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

299

0.53

1.77

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

128

1022

1.26

1.75

1.9

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

758

1.30

1.73

1.9

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

584

1.34

1.73

1.3

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

516

1.36

1.71

1.3

1.2

62.92

65.17

u/l

0.12

454

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

1.0

6.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

179

2144

0.83

1.70

3.0

3.2

566.96

2038.33

u/ml

1.44

150

1843

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

266

1.51

1.70

1.3

1.1

40.38

22.42

u/l

0.54

236

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.70

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

202

2392

0.84

1.70

1.2

1.3

204.63

253.51

u/ml

0.81

189

2192

(3019832) Treponema pallidum Ab [Presence] in Serum

202

1699

1.20

1.69

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

291

1.48

1.68

1.7

1.5

8.74

7.14

u/l

0.28

232

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

693

6345

1.10

1.67

10.7

8.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.58

1.65

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2333

22417

1.07

1.65

2.7

2.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.25

1.63

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

149

0.40

1.62

1.0

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

566

5138

1.11

1.62

1.9

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

185

1551

1.20

1.62

1.3

1.2

2.52

1.15

u/ml

0.31

136

(3025549) Creatine [Moles/time] in 24 hour Urine

2.38

1.61

1.3

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.33

1.58

1.0

1.1

—

217.78

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.33

1.58

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

136

1.69

1.58

1.2

1.4

16.56

18.03

pmol/l

0.38

109

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

1537

1.20

1.58

6.3

3.0

1.77

1.75

mg/l

0.10

169

1342

(3028026) IgM [Mass/volume] in Serum or Plasma

319

2802

1.15

1.57

1.9

2.0

1.46

1.37

g/l

0.18

285

2520

(3023103) Potassium [Moles/volume] in Serum or Plasma

4641

47160

0.93

1.57

34.8

23.5

3.97

4.01

mmol/l

18.46

4554

45985

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.27

1.55

1.0

—

(1002224) Polysomnography panel

110

1368

0.80

1.54

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

0.64

1.52

1.0

1.1

2.79

2.14

eliau/ml

—

128

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

510

1.34

1.52

2.4

2.2

4.99

1.30

u/field

1.24

273

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.33

1.52

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

476

1.35

1.52

2.0

1.9

—

5.50

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

599

1.31

1.49

1.1

1.61

1.55

g/l

0.71

538

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

359

1.40

1.47

1.0

42.85

43.53

ng/l

0.04

233

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

115

929

1.24

1.47

1.8

1.6

0.88

0.87

nmol/l

0.04

776

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

360

1.39

1.45

1.0

639.46

703.23

ng/l

0.38

230

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

454

1.35

1.45

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

454

1.35

1.45

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

454

1.35

1.45

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

449

0.67

1.43

2.4

4.2

120.64

48.31

u/ml

0.56

442

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

151

0.46

1.43

1.4

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

925

9874

0.93

1.41

5.5

4.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

251

0.56

1.40

1.3

1.7

38.33

39.65

g/l

0.40

251

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.41

1.39

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

1054

1.22

1.39

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

1.37

4.6

2.6

0.58

0.45

u/field

0.26

(3019550) Sodium [Moles/volume] in Serum or Plasma

4641

47099

0.94

1.37

34.9

23.2

139.19

139.56

mmol/l

13.66

4561

45996

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

119

1.68

1.37

1.5

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

751

1.26

1.35

1.9

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.14

1.33

1.0

1.1

—

(3016750) Collection duration of Urine

299

1.41

1.32

2.6

1.9

504.25

499.13

min

0.12

200

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

359

1.37

1.31

1.0

369.61

332.03

ng/l

0.31

236

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2538

24578

1.06

1.31

2.4

2.3

90.45

93.41

pmol/l

2.60

1446

13060

(21494434) Karyotype in Bone marrow

515

1.30

1.31

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

295

0.61

1.30

1.2

1.4

0.24

3.07

u/ml

3.04

177

(3026493) Urate [Moles/volume] in Serum or Plasma

1306

13732

0.94

1.30

3.2

3.0

358.92

361.28

umol/l

0.31

1132

11789

(44806420) Estimation of glomerular filtration rate

389

0.67

1.27

3.0

2.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

749

1.25

1.26

1.5

1.4

32.12

28.49

iu/l

0.41

629

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.40

1.24

2.7

2.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.23

1.8

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.23

1.8

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.23

1.8

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.80

1.20

2.2

1.9

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

142

0.49

1.20

1.4

18.29

13.15

mm/h

—

142

(3032057) Clostridioides difficile [Presence] in Stool

132

1.59

1.20

1.7

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.31

1.18

1.0

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

189

1.48

1.18

7.8

6.1

26.18

24.33

mmol/l

1.55

169

(3011412) CD3 cells [#/volume] in Blood

410

1.32

1.17

2.3

2.2

948.73

1076.37

e6/l

0.58

366

(3020911) Cortisol [Moles/time] in 24 hour Urine

125

1.60

1.17

1.3

1.4

71.50

437.86

nmol/24h

0.93

125

(3021387) Prolactin [Units/volume] in Serum or Plasma

721

1.24

1.17

1.9

1.7

279.68

292.34

mu/l

0.27

670

(3004616) Nuclear Ab [Presence] in Serum

567

0.74

1.17

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

455

4960

0.91

1.16

2.0

2.2

192.61

158.60

ug/g

0.90

356

3911

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2081

21517

0.95

1.15

3.6

3.1

174.24

157.08

ug/l

1.36

1891

19586

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3355

34278

0.95

1.14

4.1

4.2

15.06

15.08

pmol/l

0.22

3029

30619

(3022621) pH of Urine by Test strip

433

3962

1.10

1.13

3.5

3.0

6.12

6.07

0.54

324

2820

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.26

1.10

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

159

1837

0.86

1.09

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

268

0.63

1.08

1.8

1.4

129.46

197.70

pmol/l

1.04

268

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

738

1.22

1.08

2.1

2.2

35.83

25.50

mg/l

0.60

265

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

855

9043

0.94

1.04

1.3

1.98

1.68

u/ml

0.22

209

2221

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

195

1.44

1.04

1.8

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

195

1.44

1.04

1.7

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

162

1.48

1.03

1.7

2.0

—

(3019174) dRVVT (LA screen)

2.27

1.03

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

276

0.65

1.03

1.0

0.08

0.30

u/ml

—

101

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

670

1.23

1.03

1.3

1.2

210.95

207.10

miu/ml

0.02

237

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3560

34918

1.05

1.01

4.7

4.5

15.43

14.63

mm/h

2.00

3343

31978

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

308

1.33

0.99

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

308

1.33

0.99

1.7

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

257

1.36

0.98

2.1

2.4

439.76

503.20

e6/l

0.28

209

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.17

0.98

1.8

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

224

1.39

0.96

1.9

2.1

303.80

1281.15

e6/l

1.09

151

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3875

38109

1.05

0.95

9.8

8.3

85.08

82.67

u/l

1.75

3668

35904

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.77

0.94

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

196

2205

0.88

0.94

1.1

1.2

94.22

123.27

u/ml

0.44

753

(40757494) Bilirubin.total [Moles/volume] in Blood

294

1.33

0.93

1.9

2.3

14.08

33.49

umol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2006

19452

1.05

0.93

3.5

3.3

1778.43

1922.83

ng/l

0.70

1761

16977

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

101

1.59

0.93

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

142

0.56

0.93

1.0

1.1

—

1.72

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

217

1.38

0.93

1.3

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.63

0.90

7.4

7.0

9.94

10.16

0.17

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.63

0.90

1.1

0.85

0.67

umol/24h

—

(3028433) Virus identified in Specimen by Culture

151

1.46

0.90

1.0

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

210

1.38

0.90

1.1

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

143

1.47

0.89

1.5

1.3

92.91

27.67

g/l

0.45

112

(3029396) Erythrocyte agglutination [Presence] in Blood

2.07

0.89

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

435

4034

1.08

0.89

3.6

2.8

61.56

59.96

ml/min/173m2

0.34

208

1809

(3019420) Tryptase [Mass/volume] in Serum or Plasma

194

0.62

0.88

1.2

1.6

5.25

9.81

ug/l

1.67

171

(3016244) Insulin [Units/volume] in Serum or Plasma

152

1.45

0.87

2.0

2.5

29.58

21.37

mu/l

0.47

141

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

272

1.33

0.86

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

272

1.33

0.86

1.7

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

272

1.33

0.86

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

272

1.33

0.86

1.7

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

316

1.30

0.86

2.7

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

310

0.71

0.85

1.0

1.1

3.90

2.47

u/ml

—

136

(3017354) Segmented neutrophils/Leukocytes in Blood

659

1.20

0.85

3.5

3.9

61.38

57.90

0.69

547

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

251

0.68

0.84

2.6

1.8

331.83

295.98

mu/l

0.23

196

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

196

1.38

0.83

1.8

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

578

0.79

0.82

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

275

1.31

0.81

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

275

1.31

0.81

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

165

0.61

0.81

1.2

2.0

16.12

87.79

ug/l

—

152

(40768441) Liver Pathology biopsy report

329

1.28

0.80

1.9

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

420

1.24

0.77

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

304

1.28

0.77

1.4

1.2

135.53

91.58

u/l

0.51

259

(3008401) Mugwort IgE Ab [Units/volume] in Serum

406

0.76

0.77

1.1

0.29

1.38

u/ml

1.79

175

(3003888) Timothy IgE Ab [Units/volume] in Serum

417

0.77

1.1

5.27

4.16

u/ml

0.13

210

(4211845) Urine protein measurement

252

1.31

0.76

3.9

3.8

—

(40768806) Pleura Pathology biopsy report

779

1.17

0.75

1.3

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

482

0.79

0.75

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

493

0.79

0.75

1.2

1.1

0.71

1.63

u/ml

0.97

272

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.08

0.74

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

526

4954

1.07

0.74

2.3

2.1

0.00

0.02

estimate

1.51

906

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

271

1.29

0.74

2.9

1.8

1.54

2.65

u/field

0.77

189

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

271

1.29

0.74

3.8

3.5

1.11

1.36

0.54

271

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.64

0.73

1.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

764

8008

0.95

0.73

1.5

2.86

2.67

g/l

1.23

462

4617

(40768795) Lymph node Pathology biopsy report

502

0.80

0.73

1.2

—

(3006462) Nitrate [Presence] in Urine

228

1.32

0.72

3.8

4.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

112

1278

0.87

0.72

3.0

3.3

996.18

953.02

u/ml

0.02

104

1160

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2253

22009

1.04

0.71

2.5

2.4

76.07

79.32

nmol/l

6.12

2005

19285

(3045788) Cell count panel - Pleural fluid

739

1.17

0.70

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

117

1029

1.14

0.69

4.1

4.0

1.65

1.56

0.11

106

892

(40768443) Skin Pathology biopsy report

215

2353

0.91

0.68

1.3

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.56

0.68

1.3

1.1

600.00

845.00

titre

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

375

0.77

0.68

1.0

1.1

0.44

1.24

u/ml

0.99

192

(3023420) DNA double strand Ab [Units/volume] in Serum

190

1724

1.11

0.67

2.1

1.6

8.32

7.15

iu/ml

0.21

380

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

365

1.23

0.67

3.5

3.9

357.18

241.02

nmol/l

0.32

360

(4281824) Cell count and differential, peritoneal fluid

485

0.80

0.67

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

420

1.22

0.66

1.2

1.3

3.02

2.97

g/l

0.07

301

(3000330) Specific gravity of Urine by Test strip

316

2937

1.08

0.66

3.6

3.9

1.02

ratio

1.46

282

2666

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4573

45278

1.04

0.65

28.4

19.0

26.51

28.51

mg/l

4.42

4248

38424

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

1.44

0.65

6.8

7.6

4.84

5.32

kpa

1.50

111

(4062490) Immunoglobulin typing, IgG

412

1.22

0.65

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

327

0.76

0.65

1.0

1.1

3.39

2.30

u/ml

0.14

158

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

178

0.67

0.64

1.1

1.2

—

(3019225) pH of Specimen

575

5462

1.06

0.64

5.2

4.5

7.37

7.36

1.04

444

3856

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

261

2413

1.09

0.63

3.2

3.3

4.20

4.40

pmol/l

3.30

227

2113

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

803

1.15

0.63

1.3

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

155

1.36

0.62

2.8

7.0

63.06

69.67

0.46

119

(3020876) Protein [Mass/time] in 24 hour Urine

785

1.15

0.62

2.5

2.3

1.40

1.15

g/24h

0.45

453

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

176

0.68

0.61

1.4

1.3

12.58

15.32

pmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

105

0.57

0.61

1.3

1.5

37.63

54.31

ug/l

—

105

(44806071) Cardiolipin IgM antibody measurement

1.67

0.61

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

233

0.73

0.60

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

316

1.24

0.60

1.0

300.85

287.61

mg/l

0.54

286

(3043238) Trisomy 21 risk [Likelihood] in Fetus

138

0.65

0.60

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

825

1.14

0.60

1.5

1.4

44133.58

74735.26

e6/l

0.96

466

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

791

0.86

0.60

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

11272.40

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

629

1.16

0.60

1.8

1.5

—

(3047189) Immunofixation for 24 hour Urine

300

0.77

0.59

1.6

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

21.25

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

34.10

—

(3000034) Microalbumin [Mass/volume] in Urine

454

1.19

0.59

3.6

3.2

17.81

33.45

mg/l

1.46

346

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.71

0.57

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

123

1.38

0.57

1.1

1.3

—

(3044007) Cell count panel - Peritoneal fluid

193

1.30

0.57

2.1

1.9

—

(4146454) Self-monitoring of blood glucose

647

0.85

0.57

2.5

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

138

1247

1.11

0.56

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

420

1.19

0.56

1.2

1.3

0.44

0.43

g/l

0.09

301

(3027135) IgG subclass 1 [Mass/volume] in Serum

420

1.19

0.56

1.2

1.3

7.37

6.71

g/l

0.81

300

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

494

1.18

0.56

1.4

1.3

1.40

1.49

nmol/l

0.27

447

(3020630) Protein [Mass/volume] in Serum or Plasma

569

5430

1.05

0.55

2.2

2.6

65.06

65.88

g/l

1.63

511

4859

(3035320) C reactive protein [Mass/volume] in Body fluid

407

0.81

0.55

2.8

30.13

34.07

mg/l

0.26

316

(3003434) Protein [Mass/volume] in Pleural fluid

119

1069

1.12

0.54

1.4

1.5

33.11

31.11

g/l

1.06

106

962

(3049717) Cytology report of Urine Cyto stain

279

2607

1.07

0.54

2.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.58

0.54

1.0

1.1

0.02

0.03

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1036

0.89

0.53

1.6

1.8

77.35

3.93

iu/l

0.48

387

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

143

1301

1.10

0.52

2.5

2.2

183.08

113.32

ug/min

0.59

716

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

196

1.28

0.52

2.1

1.8

79.80

50.42

ug/l

0.51

189

(3045424) Erythrocytes [Presence] in Urine

271

2535

1.07

0.52

2.3

2.1

0.00

0.02

estimate

0.92

685

(3006571) Granulocytes/Leukocytes in Synovial fluid

601

1.15

0.51

1.6

1.5

56.36

62.63

0.74

384

(3047352) Trisomy 18 risk [Likelihood] in Fetus

134

0.67

0.51

1.6

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.50

0.51

6.7

5.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

138

1257

1.10

0.50

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

106

952

1.12

0.50

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

435

1.17

0.50

2.6

2.0

724.49

655.16

0.41

249

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

258

0.77

0.50

1.1

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

118

1.36

0.50

1.2

1.3

26.71

33.55

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

566

1.15

0.49

1.2

1.3

9.33

13.48

u/l

2.74

523

(3026389) Candida sp identified in Specimen by Organism specific culture

616

0.86

0.49

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

136

1.32

0.49

2.6

2.4

31.17

29.40

0.17

121

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

107

0.65

0.48

1.6

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

502

1.16

0.48

1.6

—

(3014891) Appearance of Pleural fluid

110

0.64

0.48

1.1

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

106

1174

0.90

0.48

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

598

5742

1.05

0.48

1.4

1.3

623.08

491.97

titre

0.74

130

1277

(40765089) Chromosome analysis panel - Blood by G-banded

1.49

0.47

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

138

1263

1.09

0.47

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

263

1.22

0.47

2.2

2.7

37.13

37.92

0.10

145

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

1.35

0.46

1.5

12.20

9.35

ug/l

1.17

111

(3005988) Vibrio sp identified in Specimen by Organism specific culture

654

0.87

0.46

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

103

930

1.11

0.46

1.4

1.5

4203.96

3123.73

e6/l

0.15

650

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

203

1891

1.08

0.46

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1337

13052

1.03

0.45

3.6

3.3

0.05

0.06

0.08

463

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

651

0.87

0.44

1.3

1.4

—

(40762814) Titanium [Mass/volume] in Blood

1.37

0.43

2.5

2.2

6.98

3.46

ug/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

0.70

0.43

1.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

396

1.16

0.42

2.7

2.0

676.68

2812.85

u/l

1.16

149

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

897

1.11

0.42

1.1

2.84

3.91

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

648

0.88

0.42

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

176

1.25

0.41

1.4

1.5

11.71

13.97

g/l

0.43

132

(40761539) Cells [Type] in Urine sediment by Light microscopy

150

0.73

0.41

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

538

1.13

0.41

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

17.94

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

261

0.80

0.41

1.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

3.56

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

174

1623

1.07

0.40

4.3

4.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

1.35

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.44

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

34.87

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

140

1509

0.93

0.38

1.7

1.6

21.37

27.75

u/ml

0.49

258

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

108

1177

0.92

0.38

1.4

1.2

12.95

6.37

u/ml

0.33

171

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.38

1.6

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

0.76

0.38

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

618

1.12

0.38

1.1

1.23

1057.16

iu/ml

0.52

122

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

107

1.31

0.37

1.1

1.2

381.71

274.38

pmol/l

1.00

(3036071) Salmonella sp Ab [Titer] in Serum

114

0.70

0.37

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

224

0.80

0.36

1.1

—

(3024263) Appearance of Synovial fluid

278

0.83

0.36

1.2

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.33

0.35

1.0

1.2

16.00

19.71

u/l

—

(40765096) Chromosome analysis panel by Banding

179

0.78

0.35

1.4

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

469

0.87

0.35

1.1

—

3.13

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1362

13356

1.03

0.35

4.7

3.8

0.12

0.28

estimate

0.48

473

4352

(3047007) Chlamydophila sp Ab [Presence] in Serum

458

0.87

0.34

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

126

1171

1.08

0.34

3.7

3.8

25.54

30.33

mg/l

0.81

872

(3003329) Lymphocytes/Leukocytes in Synovial fluid

467

0.88

0.33

1.9

1.4

28.25

26.69

0.12

289

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.69

0.33

1.3

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.69

0.33

4.7

2.9

4635.83

1572.88

u/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.68

0.33

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

303

1.16

0.32

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

164

1.22

0.32

1.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

847

1.09

0.31

2.1

32.41

32.52

0.08

842

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

800

0.91

0.31

1.5

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

684

1.10

0.31

2.0

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

653

0.90

0.31

3.2

3.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

286

1.15

0.31

1.2

—

(4035726) Immunohistochemistry procedure

477

4618

1.04

0.30

1.5

1.4

—

(3036603) Volume of Urine

357

0.87

0.30

1.3

1.7

1975.71

1829.38

0.33

351

(40761536) Microorganisms panel - Urine sediment

422

4078

1.04

0.29

6.1

4.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

107

0.75

0.29

1.6

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

1.23

0.28

6.8

7.3

6.09

5.98

kpa

0.27

111

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

285

2966

0.96

0.28

2.3

2.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

699

1.09

0.28

1.4

1.5

0.90

0.84

g/l

0.21

540

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

1505

0.94

0.28

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

158

1.20

0.28

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

355

1.13

0.28

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

710

1.09

0.27

1.2

1.4

6.02

6.20

mmol/l

0.24

658

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

279

0.86

0.27

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.21

0.26

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

1.25

0.26

1.5

1.2

525.85

45.69

mg/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

110

1172

0.94

0.26

1.4

1.2

1.93

3.10

u/ml

0.87

103

(21494890) Protein electrophoresis panel - 24 hour Urine

655

0.91

0.26

1.9

2.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.23

0.25

1.0

1.2

15.61

6.68

mg/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

282

1.14

0.25

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

232

2227

1.04

0.24

1.6

15.80

18.94

iu/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.74

0.24

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

662

0.92

0.24

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

671

0.92

0.23

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

369

0.89

0.23

1.3

1.2

86.03

107.02

pmol/l

1.83

369

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1.12

0.22

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

116

1.21

0.22

1.6

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

191

1.15

0.21

1.2

41.28

40.19

g/l

0.14

(3035880) pH of Pleural fluid

391

1.10

0.21

1.2

1.3

7.41

0.05

270

(3021589) Normoblasts [#/volume] in Blood

2141

21201

1.01

0.21

14.9

12.5

0.00

e9/l

0.33

1758

17117

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.79

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.08

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

478

1.09

0.21

1.2

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

223

2313

0.96

0.21

2.5

2.4

0.88

1.16

g/l

0.48

189

1936

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

110.57

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

102

1079

0.94

0.21

1.7

—

44.59

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.15

—

(21494814) CD8 cells/Lymphocytes in Specimen

192

1.15

0.20

2.5

1.9

29.09

31.83

0.42

192

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

166

0.84

0.20

1.4

1.5

1.05

1.17

ratio

—

107

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

166

0.84

0.20

1.4

1.5

0.97

0.96

ratio

—

107

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

166

0.84

0.20

1.4

1.5

1.20

1.15

ratio

—

107

(3009214) Lutropin [Units/volume] in Serum or Plasma

780

1.06

0.20

1.5

1.4

12.89

9.50

u/l

0.98

616

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

2.9

—

3.21

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

297

1.11

0.20

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

297

1.11

0.20

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

259

1.12

0.20

1.3

1.31

1.18

nmol/l

0.24

176

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

111

0.81

0.20

1.1

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.20

0.19

1.7

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

165

0.85

0.19

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

654

0.93

0.19

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

821

1.06

0.19

1.4

1.2

96.10

47.77

u/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.15

0.19

1.8

1.5

50.50

46.58

umol/l

—

(3000012) Reticulocyte production index

110

1047

1.05

0.18

2.0

1.00

0.88

1.23

710

(3000494) Fungus identified in Specimen by Culture

561

5717

0.98

0.18

1.6

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.17

0.17

1.1

1.7

—

77.41

—

(3045142) Bone marrow Pathology biopsy report

661

0.94

0.17

1.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

886

0.95

0.17

2.2

2.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

681

0.94

0.17

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

110

1.18

0.17

1.2

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

1061

1.05

0.16

2.1

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.14

0.16

2.1

1.9

25.86

42.25

pmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

196

1.12

0.16

1.7

1.9

1617.89

19455.16

e6/l

—

109

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

292

1.10

0.16

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

177

1.13

0.16

1.7

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

111

1.17

0.15

1.2

0.57

1.84

mmol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

143

1483

0.96

0.15

1.2

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

328

0.91

0.15

4.6

5.7

26.41

50.02

u/ml

0.99

(3035933) Granulocytes/Leukocytes in Blood

100

1045

0.96

0.15

5.0

3.4

60.44

58.57

0.75

100

1045

(3003740) Influenza virus B Ag [Presence] in Specimen

451

0.93

0.15

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

342

1.08

0.15

1.9

2.1

1.79

2.03

ug/l

0.35

284

(3006442) Creatine [Moles/volume] in Serum or Plasma

313

1.09

0.15

2.4

1.7

124.44

93.04

umol/l

0.30

313

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

517

1.06

0.14

1.2

1.6

42.00

27.65

u/ml

—

108

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

188

1937

0.97

0.14

1.6

1.8

39.48

38.99

u/l

0.10

157

1667

(3032773) Endomysium IgG Ab [Titer] in Serum

377

0.93

0.13

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

588

1.05

0.13

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

1.15

0.13

1.8

1.4

—

(3006270) Folate [Moles/volume] in Blood

472

1.06

0.12

1.1

1.2

346.85

327.77

nmol/l

0.25

367

(3020491) Glucose [Moles/volume] in Blood

355

1.07

0.12

1.6

2.3

6.99

6.97

mmol/l

0.01

242

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

262

2676

0.98

0.12

2.4

2.3

4.05

4.18

g/l

2.16

238

2407

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

453

1.06

0.12

1.6

1.5

—

(4015189) Microbial culture of sputum

158

0.89

0.12

2.4

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

767

1.04

0.12

1.7

1.9

4.89

4.58

mmol/24h

0.29

650

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

189

1843

1.03

0.11

2.3

0.00

g/l

0.79

164

1590

(3022689) Creatine [Moles/volume] in Urine

147

0.88

0.11

2.4

1.5

7.98

7.17

mmol/l

0.49

147

(36660697) Celiac disease serology panel - Serum

309

3146

0.98

0.11

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

448

4542

0.99

0.10

4.4

4.2

0.14

0.12

0.18

157

1343

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

105

1017

1.03

0.10

1.3

1.2

111.43

266.37

titre

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.15

0.10

1.3

1.2

182.33

373.03

u/l

—

(40758558) Short blood count panel - Blood

1480

14701

1.01

0.10

7.8

6.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

900

0.97

0.10

1.0

1.1

2.58

8.42

eliau/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.09

1.2

2.94

1.73

umol/24h

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

195

1909

1.02

0.09

2.3

0.00

0.05

g/l

3.28

174

1687

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

116

1.12

0.09

1.5

1.4

7.00

7.69

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

262

1.07

0.09

1.2

1.3

39.01

28.46

u/l

0.69

213

(3025018) Bordetella pertussis Ab [Titer] in Serum

196

0.92

0.09

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

451

0.95

0.08

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

166

1625

1.02

0.08

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.05

0.08

1.2

1.3

62.50

67.61

ug/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

2321

1.02

0.08

2.5

2.3

10.32

10.35

g/l

0.03

207

2019

(4212803) Bone marrow aspirate examination

0.77

0.08

1.4

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

236

0.93

0.08

1.8

1.4

3.90

3.21

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

175

1716

1.02

0.08

2.4

2.3

0.00

g/l

-0.00

164

1585

(3014599) Egg white IgE Ab [Units/volume] in Serum

123

0.89

0.08

1.0

1.1

—

1.71

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

263

2669

0.98

0.08

2.3

3.73

3.75

g/l

0.04

239

2398

(3037692) Legionella sp identified in Specimen by Organism specific culture

195

1.08

0.08

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

264

2677

0.99

0.07

2.3

7.42

7.49

g/l

0.24

240

2403

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

254

2503

1.02

0.07

1.2

1.3

57.49

59.44

au/ml

0.05

172

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

235

1.06

0.07

1.3

371.41

509.05

ug/l

0.13

121

(3041918) Cholesterol [Moles/volume] in Pleural fluid

138

1.09

0.06

1.1

1.2

1.48

mmol/l

—

(3033099) Centromere Ab [Titer] in Serum

102

0.88

0.06

1.4

1.1

—

(3012441) Differential panel - Pleural fluid

820

1.02

0.06

1.4

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3569

35617

1.00

0.05

35.2

25.1

331.44

331.22

g/l

0.72

3529

35321

(3025941) Bacteria identified in Stool by Culture

228

2307

0.99

0.05

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

141

1387

1.02

0.05

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

323

0.96

0.05

3.0

4.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

132

1340

0.98

0.04

1.6

1.5

0.17

9.51

iu/ml

0.94

276

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

217

2146

1.01

0.04

2.7

3.1

3.10

5.59

ratio

0.68

138

1276

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

575

1.03

0.04

2.0

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

121

1191

1.02

0.04

1.5

1.9

13.17

12.44

mg/l

0.29

104

1091

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

476

1.03

0.04

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

277

2745

1.01

0.04

2.4

2.5

23.76

23.42

au/ml

0.02

209

(3000570) Elastase.pancreatic [Mass/mass] in Stool

160

1580

1.01

0.04

1.4

1.5

246.00

264.86

ug/g

0.55

987

(3025159) Blasts/Leukocytes in Blood

449

4517

0.99

0.04

4.6

4.3

0.62

0.16

0.58

152

1252

(3000919) Neutrophils/Leukocytes in Pleural fluid

210

1.05

0.03

1.2

1.4

27.33

17.57

0.91

191

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

371

0.97

0.03

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

112

1.07

0.03

1.8

1.2

1.19

1.18

mmol/l

0.23

112

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

239

2373

1.01

0.02

2.7

3.2

33.78

60.11

mg/l

2.98

203

1992

(3002179) Metamyelocytes/Leukocytes in Blood

450

4519

1.00

0.02

4.3

4.1

0.88

0.69

0.72

179

1459

(4024509) Urine culture

249

2473

1.01

0.02

2.1

2.0

—

(3002619) Bacteria identified in Specimen by Culture

122

1.07

0.02

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

225

2265

0.99

0.02

2.4

2.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

420

1.02

0.02

1.7

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

477

4753

1.00

0.02

4.4

4.2

1.16

0.99

0.71

186

1552

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

378

0.98

0.01

1.7

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

137

1380

0.99

0.01

1.6

1.5

11374.77

14927.14

e6/l

0.92

949

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.04

0.01

1.3

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

353

1.02

0.01

2.1

2.0

2.50

3.69

ug/l

1.06

323

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

107

1077

0.99

0.01

1.2

1.3

32.50

37.88

u/l

0.23

917

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

126

0.95

0.00

3.0

2.2

4.25

289.63

ug/l

0.68

126

(3051101) Glucose [Moles/volume] in Cord blood

114

1.05

0.00

2.9

6.6

8.53

8.85

mmol/l

0.28

114

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

214

1.03

0.00

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

2476

1.00

0.00

2.4

2.3

3.00

2.96

g/l

0.24

222

2202

(37208534) Antinuclear antibody arbitrary concentration in serum

123

0.98

0.00

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

139

1.01

0.00

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

139

1.01

0.00

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

139

1.01

0.00

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

139

1.01

0.00

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

516

1.01

0.00

1.4

1.3

82871.24

76157.03

e6/l

0.05

347

(3017704) Immunofixation for Urine

353

0.99

0.00

1.9

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

170

1.00

0.00

1.0

1.3

6.15

6.20

mmol/l

0.08

161

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

150

1.00

0.00

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

726

1.01

0.00

1.2

1.3

385.96

406.14

u/l

0.08

687

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

368

1.01

0.00

1.7

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

543

0.99

0.00

1.1

41.22

22.48

au/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

283

0.99

0.00

2.3

2.1

118.75

139.47

ug/min

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

238

2376

1.00

0.00

2.7

3.2

52.27

81.95

mg/l

0.66

202

1997

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

721

1.00

0.00

1.1

—

0.83

—

(3013727) Leukocytes other/Leukocytes in Blood

187

1.02

0.00

4.5

4.0

44.58

53.53

1.21

175

(3023511) Choriogonadotropin [Units/volume] in Urine

148

1.01

0.00

1.3

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

255

0.98

0.00

1.4

1.5

16.41

7.00

u/l

0.49

215

(3050129) First trimester maternal screen panel - Serum or Plasma

203

0.98

0.00

1.5

—

(3025130) Human papilloma virus identified in Specimen

321

1.00

0.00

1.9

1.8

—

(3037756) Immunofixation for Serum or Plasma

146

1465

1.00

0.00

1.5

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

586

1.01

0.00

1.2

1.1

—

20.70

u/ml

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.49

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.99

-0.00

1.3

1.1

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.91

-0.00

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

2.84

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.93

-0.00

1.2

1.6

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.02

-0.00

11.0

10.3

0.24

0.26

—

(3001729) Color of Synovial fluid

0.98

-0.00

1.6

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.94

-0.00

1.4

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.96

-0.00

1.1

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.00

-0.00

1.5

1.3

—

829.06

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.86

-0.00

2.2

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

0.98

-0.00

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1364.44

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.93

-0.00

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(4133840) Spirometry

0.91

-0.00

1.1

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

299.33

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.3

—

17.84

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_ICH and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_ICH	2.719 [2.45, 3.02]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 8418 out of 15911 females with I9_ICH died.

Males

Parameter	HR [95% CI]	p-value
I9_ICH	2.682 [2.41, 2.99]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 9468 out of 18816 males with I9_ICH died.

Mortality risk

Mortality risk for people of age

years, who have I9_ICH.

N-year risk	Females	Males
1	0.171%	0.377%
5	1.531%	2.647%
10	3.57%	6.822%
15	6.276%	12.305%
20	11.045%	20.278%

Relationships between endpoints

↥

Index endpoint: I9_ICH – Intracerebral haemorrhage

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Intracerebral haemorrhage

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints